Summarizing articles

User Generated

xevfgvarg

Writing

Description

Write up a summary of 2-3 pages long on each article below. Please make sure each article is separately written in MLA format, and sent back to me. As there are two articles in the files, therefore I need a minimum of 2 pages for each one of the summaries for the articles!!

Unformatted Attachment Preview

ISSN 0233-7657. Biopolymers and Cell. 2010. Vol. 26. N 2 Vitamin D – a novel role in pregnancy Chander P. Arora , C. J. Hobel 1, 2 1, 2 1 Cedars-Sinai Medical Center, Burns-Allen Research Institute and the Division of Maternal-Fetal Medicine 8635, West Third St., Ste 160W, Los Angeles, CA, USA, 90048 2 David Geffen School of Medicine, University of California Los Angeles 10833, Le Conte Avenue, Los Angeles, CA, USA, 90095 arora@cshs.org Vitamin D regulates placental development and function. It is a potent regulator of the immune systemstimulating antimicrobial responses while suppressing inflammation. Its deficiency has been linked to increased risk of serious chronic and inflammatory diseases. Vitamin D deficiency during pregnancy increases susceptibility to infection and inflammation, leading, in turn, to outcome like preterm birth or preeclampsia. Pregnant women with darker skin pigmentation are more likely to be vitamin D deficient, particularly when living in regions with low exposure to sunlight. It is possible that during pregnancy, a primary non-infectious inflammatory process is activated by vitamin D deficiency. Combined assessment of vitamin D deficiency and inflammatory markers in early pregnancy or during different stages of pregnancy may facilitate the recognition of the risk of complications. Keywords: vitamin D, pregnancy, immune response. Introduction. Beyond its classical effects on bone and calcium homeostasis causing rickets and osteoporosis, vitamin D has become increasingly recognized as a potent regulator of multiple physiological functions. Vitamin D can be obtained from limited food sources, such as fatty fish and fish oil, and, today, from dietary supplements or we can also make it ourselves, through a chemical reaction that happens in the skin when it is exposed to ultraviolet B (UVB) light especially to meet the increased demands of pregnancy. The vitamin D deficiency epidemic during pregnancy is caused by a lack of adequate sunlight exposure needed to synthesize vitamin D3 (cholecalciferol) in the skin, coupled with oral intakes that are too low even with regular use of prenatal vitamins containing 400 IU vitamin D3 [1]. Vitamin D deficiency during pregnanÓ Institute of Molecular Biology and Genetics NAS of Ukraine, 2010 cy has been linked with a number of serious short- and long-term health problems in offspring, including impaired growth, skeletal problems, type 1 diabetes, asthma, and schizophrenia [2]. Functional aspects of vitamin D. Vitamin D in humans, refers to Vitamin D3, which is also known as cholecalciferol. In response to UVB light, it is created by skin cells called keratinocytes utilizing 7-dehydrocholesterol, a product of cholesterol. This version has no biological activity in the body till this molecule is modified primarily in the liver, by a series of related enzymes for hydroxylation, to generate 25-hydroxyvitamin D3 (25(OH)D3). The 25(OH)D3 made by the liver is nonetheless the major circulating form of vitamin D. When it is needed in the body, a final conversion to the biologically active form by the enzyme 1a-hydroxylase (CYP27b1), is required to become 1,25-dihydroxyvitamin D (1,25(OH)2D3). This was first discovered in 97 CHANDER P. ARORA, HOBEL C. J. 20 18 7-dehydro-cholesterol 11 9 12 Skin (Keratinocytes) HO 17 26 23 27 15 25 8 OH 7 6 4 3 24 25 22 21 5 2 CH2 10 1 Vit D (D3 / Cholocalciferol) 25 CH2 OH HO Liver 25(OH) Vit D3 (circulating form) CH2 1 a-hydroxylase (CYP27b1) Kidneys and other tissues 1 HO OH 1,25(OH)2 Vit D3 (active form) Fig. 1. Skin keratinocytes convert 7-dehydrocholesterol to vitamin D in response to sunlight exposure. This is converted to the circulating form 25(OH)D 3 in liver and to 1,25(OH) 2D 3 in the target tissues the kidney, and renal processing is responsible for generating much of the body’s circulating 1,25(OH)2D3 supply [3] (Fig. 1). The active form of vitamin D, the 1,25(OH)2D3 molecule virtually functions as an «on/off» switch for genes of every tissue in the human body. This form of vitamin D acts by attaching to the vitamin D receptor (VDR), which serves as a transcription factor inside a cell’s nucleus. Once bound to 1,25(OH)2D3, the VDR protein makes a complex with retinoid-x receptor (RXR). This complex now binds to a specific region of the cell’s DNA adjacent to a target gene. Their attachment to the DNA induces cellular machinery to begin transcribing the neighboring gene to a specific protein. Recently, many other tissues, including cells of the immune system and the skin, have been identified to perform the conversion of 25(OH)D3. Skin is therefore unique among organs in that it is capable of manufacturing biologically active 1,25(OH)2D3 in the presence of UVB light from start to finish, although local production of 1,25(OH)2D3 from circulating in other tissues is a substantial source of vitamin D’s biological activity. 98 By inducing a cell to make a particular protein, 1,25(OH)2D3 affects a range of cellular function, and this ability to trigger gene activity in different tissues is the basis of vitamin D’s enormous physiological effects. Precisely, vitamin D is manufactured in one tissue and circulates through the body influencing many other tissues, and VDR is a nuclear receptor that responds to powerful steroidal hormones such as estrogen and testosterone [4]. At least 1,000 different genes are believed to be regulated by 1,25(OH)2D3, including several involved in the body’s calcium processing that account for D’s well-known role in bone formation as well as genes with critical roles in a variety of cellular defenses. Circulating levels of 25(OH)D3 – the biomarker of vitamin D status. Circulating levels of 25(OH)D3 are a direct reflection of vitamin D status, which depends on access to vitamin D either through exposure to sunlight or through dietary intake whereas serum concentrations of 1,25(OH)2D3, are primarily defined by the endocrine regulators of renal CYP27b1 activity. The net effect of this is that vitamin D status can vary VITAMIN D – A NOVEL ROLE IN PREGNANCY 25(OH) D Sufficient 30–60 ng per milliliter or 75–150 nmol/l 1ahydroxylase 1,25(OH)2 D Active Form (Target Tissues) Insufficient 20–30 ng per milliliter or 50–75 nmol/l Deficient 20 ng per milliliter or 50 nmol/l Fig. 2. Deficient and Sufficient levels of circulating vitamin D for getting converted to the active form by the action of 1a-hydroxylase significantly in populations as a consequence of geographical, social or economic factors. Until recently, rickets was considered to be the only significant clinical consequence of low serum 25(OH)D3. However, an entirely new perspective on vitamin D deficiency has arisen from the observation that serum 25(OH)D3 levels correlate inversely with serum parathyroid hormone below a threshold of 80 nmol/l 25(OH)D3 [5]. This has led to a complete re-evaluation of the optimal serum level of 25(OH)D3 so that serum concentrations of 25(OH)D3 up to 75 nmol/l are now considered to be inadequate and are more commonly referred to as vitamin D «insufficiency» as opposed to «deficiency» [6]. A 25(OH)D3 level of 30 ng per milliliter (75 nmol/l) or higher provides adequate substrate for 1-OHase to convert 25(OH)D3 to its active form, 1,25(OH)2D3 [6]. We categorized the serum levels of 25(OH)D3 as: less than 50 nmol/l (< 20 ng per milliliter) as deficient, 50– 75 nmol/l (< 20–30 ng per milliliter) as insufficient, and 75–150 nmol/l (< 30–60 ng per milliliter) as sufficient (Fig. 2). Once 1,25(OH)2D3 completes the task of maintaining normal cellular proliferation and differentiation, it induces expression of the enzyme 25-hydroxyvitamin D-24-hydroxylase (24-OHase), which enhances the catabolism of 1,25(OH)2D3 to biologically inert 1,24,25trihydroxyvitamin D. Locally produced 1,25(OH)2D3 does not enter the circulation and has no influence on calcium metabolism. Therefore circulating levels of 25(OH)D3 are a direct reflection of vitamin D status, which depends on access to vitamin D either through exposure to sunlight or through dietary intake. Vitamin D requirements during pregnancy. In addition to causing poor global mineralization of the skeleton, vitamin D deficiency has implications for numerous other nonskeletal health outcomes. In utero or early life vitamin D deficiency has been linked to an increased risk of type 1 diabetes [7], asthma [8], and schizophrenia [9, 10]. Fascinating new data also show that vitamin D regulates placental development and function [11], which suggests that maternal vitamin D status may be associated with adverse outcomes of pregnancy, such as miscarriage, preeclampsia, and preterm birth. Preterm delivery in the environment of infection is believed to result from the actions of pro-inflammatory cytokines secreted as part of the maternal and/or fetal host response to microbial invasion [12, 13]. Enhanced expression of the pro-inflammatory cytokines IL-1, IL-6 and TNFa are associated with preterm delivery [14]. Such cytokines have been detected in elevated concentrations in the amniotic fluid and plasma of women with preterm labor and human gestational tissues are potentially rich sources of inflammatory cytokines [15]. These cytokines can be induced by a number of stimuli, including bacterial endotoxins, and they have been shown to promote spontaneous labor and rupture of membranes via their actions on the gestational tissues [16–18]. Several studies have reported altered levels of CYP27b1 in placentas from preeclampsia pregnancies [19, 20]. Furthermore, in a recent nested case-control study of pregnant women Bodnar and colleagues showed that vitamin D deficiency significantly increases the risk of preeclampsia [1]. This coupled with evidence of the prevalence of vitamin D insufficiency in pregnant mothers – particularly African-American mothers [1] – has supported a role for vitamin D sufficiency in protecting against this prevalent complication 99 CHANDER P. ARORA, HOBEL C. J. of pregnancy [21]. There was no significantly altered expression of vitamin D receptor (VDR) or CYP27b1 in pregnancies with intrauterine growth restriction (IUGR) [22]. More recent studies of vitamin D insufficiency during pregnancy and lactation have served to underline the magnitude of the problem [1, 3, 4, 23, 24]. Our research group recently reported vitamin D deficiency in a cohort study of spontaneous preterm pregnancies (N = 27) compared to matched case controls (N = 32) in an NIH Behavior In Pregnancy Study (BIPS). In the study, serum samples were collected in 528 ethnically diverse women at 18–20 weeks (T1), 28–30 weeks (T2) and 34–36 weeks (T3). The results indicated deficient vitamin D status in the subjects who delivered preterm (PTB group) but sufficient vitamin D levels in controls at all three visits. We assessed the involvement of vitamin D in the occurrence of IL-6 levels in women with spontaneous preterm birth. At all three time intervals, significantly higher levels of IL-6 were associated with the preterm birth cases as compared to the controls [25]. Significantly higher levels of this pro-inflammatory cytokine, IL-6 were found in subjects with IUGR as compared with controls. This also correlated with lower serum vitamin D levels in this cohort. It is possible that a non-infectious inflammatory response is activated by vitamin D deficiency that is a marker of risk for or causative in preterm birth or development of IUGR [26]. Racial disparity in vitamin D synthesis. Since the most important source of vitamin D is the skin’s synthesis of the vitamin from UVB solar radiation [27]. Any process that reduces UVB photons from entering the epidermis will diminish cholecalciferol (vitamin D3) production. The skin pigment melanin absorbs UVB photons and can reduce vitamin D3 synthesis by 90 % [28]. Consequently, African Americans are at high risk of vitamin D deficiency. According to CDC, 42 % of African-American women in US between the ages of 15–49 years are deficient in vitamin D (less than 20 ng per milliliter of serum levels) [29]. Nevertheless, it is also clear that some groups are more at risk of vitamin D insufficiency than others. The 1988–1994 National Health and Nutrition Examination Survey revealed that 42 % of AfricanAmerican women of child-bearing age had 25(OH)D3 100 levels that were lower than 50 nmol/l, half the current optimal target level. This compares with only 4 % of white women [23]. We recently reported vitamin deficiency in cohort study of African-American pregnancies compared to Caucasians. Although the cohort used had women who delivered at term, the levels of 25(OH)D3 in Caucasians were significantly lower in the subjects with infection than the ones without (p < .001). Women with vitamin D insufficiency in the second trimester were more likely to develop infection during pregnancy but not subjects with sufficient vitamin D at T1. The proportion of infection percent in the Caucasian and AfricanAmerican groups was significantly different at all the time periods as well as their levels of 25(OH)D3. African Americans show a trend to have higher proportion of infections than the Caucasian group at all three visits and had significantly lower 25(OH)D3 (p < .001) at these visits [30]. Our results reveal a positive association between 25(OH)D3 concentrations and elevated risk of infection [31]. Vitamin D insufficiency may, therefore be involved in the pathogenesis of maternal infection during pregnancy. Vitamin D levels could modulate this infection susceptibility during pregnancy. In another study, approximately 29 % of Black pregnant women and 5 % of white pregnant women residing in the northeastern United States had vitamin D deficiency, i. e. serum 25(OH)D3 of less than 50 nmol/l, whereas 54 % of Black women and 47 % of white women had serum 25(OH)D3 levels indicative of vitamin D insufficiency, i. e. 25(OH)D3 of 50–75 nmol/l [1]. Immunomodulation by vitamin D. Recently vitamin D deficiency and even insufficiency has become a worldwide issue affecting the populations across the globe. The broader implications of vitamin D restrictions especially with the growing trend of sun-blocks, have become more evident. Vitamin D status has been found to be a major contributing factor to immune response [32]. Precisely, the active form of vitamin D, 1,25(OH)2D3 has been shown to be the key modulator of immune responses [33, 34]. The degree to which inflammatory pathways play a role in labors that are not associated with clinical signs of infection is unknown, however even normal labor shares certain characteristics with inflammatory processes. VITAMIN D – A NOVEL ROLE IN PREGNANCY Fig. 3. Macrophage cells respond to bacterial cell walls by manufacturing both VDR proteins and the enzyme (1-OHase) that converts circulating 25(OH)D 3 into the biologically active 1,25(OH)2D 3. These events induced the immune cells to start producing cathelicidin that demonstrates antimicrobial activity against a variety of bacteria Liu [35] substantially advanced this line of investigation by showing that human immune cells respond to infection by manufacturing both vitamin D receptor proteins and the enzyme that converts circulating 25(OH)D3 into the biologically active 1,25(OH)2D3 and to induce the immune cells to start producing cathelicidin. Cathelicidin, the naturally produced antimicrobial agent that acts against a variety of bacteria, explaining the tuberculosis sunshine cure: the sun-soaked skin could boost their immune cells to generate the natural antibiotic that fought off the tuberculosis bacteria (TB) (Fig. 3). In particular, the active form of vitamin D, 1,25(OH)2D3 has been shown to be a key modulator of immune responses [36, 37]. Both the receptor for 1,25(OH)2D3, VDR [36, 38] and the enzyme that catalyzes the synthesis of 1,25(OH)2D3 from precursor 25(OH)D, CYP27b1 [39, 40] are abundantly expressed by cells from the immune system. The presence of CYP27b1 in macrophages [41] and dendritic cells [42] indicates that local (autocrine 25(OH)D3 or paracrine) synthesis of 1,25(OH)2D3 is a pivotal feature of vitamin D action within the immune system. Placental production of vitamin D. The placenta was one of the first extra-renal sites shown to synthesize 1,25(OH)2D3 from 25(OH)D3 [43, 44]. Organiza- tion of 1a-hydroxylase, the enzyme needed to convert 25(OH)D3 to the active form is localized both in maternal decidua and fetal trophoblasts and is more abundant in first and second trimester. We detected highest levels of 25(OH)D3 at 18–20 weeks of pregnancy in the study as well as control group. This could also be due to the presence of VDR in the placenta as has been suggested by Bruns and Bruns [45]. This means that vitamin D functions in an autocrine fashion at the fetal-maternal interface [45]. One possible explanation is that 1,25(OH)2D3 functions as a regulator of placental calcium transport in addition to an immunomodulatory function [46]. From the studies highlighting immunological function of the heterogeneous cells that make up the placenta, maternal and fetal cells are able to mediate innate [47, 48] and adaptive [49, 50] immune responses. Furthermore, a series of studies using human placentas [11, 22] have demonstrated the expression of CYP27b1 (gene for producing the enzyme 1a-hydroxylase) in decidua (maternal tissue) and trophoblast (fetal tissue) [11, 22]. Within deciduas, CYP27b1 is expressed by both stromal cells and macrophages, while in trophoblasts CYP27b1 is localized predominantly in the syncytiotrophoblast (the cells that form the barrier between maternal and fetal blood) [22]. In primary cultures of human decidual cells, both 1,25(OH)2D3 and 25(OH)D3 (the latter metabolized endogenously to 1,25(OH)2D3) induced expression of antimicrobial cathelcidin, but suppressed the inflammatory cytokine production [32]. Within the decidua, the gene expression for this enzyme (CYP27b1) was identified in decidual stromal cells as well as the decidual macrophages, suggesting a possible immunomodulatory function for localized synthesis of 1,25(OH)2D3 [11, 22]. Vitamin D appears to be the trigger for antibacterial/anti-inflammatory responses in decidual and trophoblastic cells. Analysis of decidual cells in vitro has endorsed a possible role for 25(OH)D3 and 1,25(OH)2D3 as modulators of immune responses in maternal tissue [32]. Human decidual cells from 1st trimester placentas incubated for 24 hrs with 25(OH)D3 or 1,25(OH)2D3 showed induction of cathelicidin and suppression of cytokines such as IL-1, TNFa and IL-4 [32]. The fact that a physiological dose of 25(OH)D3 (100 nmol/l) was as ef101 CHANDER P. ARORA, HOBEL C. J. fective as a pharmacological dose of 1,25(OH)2D3 (100 nmol/l), underlines the importance of localized (placental) versus endocrine (systemic) synthesis of 1,25(OH)2D3. Using primary human placental tissue and trophoblastic cells it has been shown that the fetal side of the placenta also induces cathelicidin-mediated antibacterial response to treatment with vitamin D metabolites. Collectively these data indicate that exogenous 1,25(OH)2D3 or locally metabolized 25(OH)D3 are capable of inducing anti-bacterial and anti-inflammatory responses in both the maternal and fetal components of the placenta [22]. In addition to stromal and trophoblastic cells, the placenta is made up of an array of leukocytes that are fundamental to the immunology of gestation. It has been shown that the most abundant of the decidual immune cells, uNK, do not express CYP27b1 [22] but are potential targets for paracrine responses to 1,25(OH)2D3 synthesized by stromal cells or macrophages. By contrast, decidual macrophages express abundant levels of CYP27b1 and may therefore support the same autocrine vitamin D-induced innate immunity demonstrated in peripheral blood-derived macrophages. In the case of the latter the specific antibacterial responses such as toll-like receptor (TLR)-mediated induction of cathelicidin are highly dependent on vitamin D status [51]. When a macrophage or monocyte is stimulated through its toll-like receptor 2/1 (TLR2/1) by an infectious agent such as Mycobacterium tuberculosis or pathogen-associated molecules such as lipopolysaccharide, the signal up-regulates expression of the VDR and the enzyme D-1a- hydroxylase (1-OHase), stimulating the production of active vitamin D. The active form 1,25(OH)2D3 travels to the nucleus, where it increases the expression of cathelicidin, a peptide capable of promoting innate immunity and inducing the destruction of infectious agents such as M. tuberculosis. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the VDR and is strongly upregulated in myeloid cells by 1,25-dihydroxyvitamin D3 [51]. It is also likely that the 1,25(OH)2D3 produced in monocytes or macrophages is released to act locally on activated T lymphocytes, which regulate cytokine synthesis, and activated B lymphocytes, which regulate 102 immunoglobulin synthesis. The autocrine synthesis of 1,25(OH)2D3 that drives innate immune responses is dependent on the availability of substrate 25(OH)D3 (Fig. 3). It has been shown that Caucasian levels of cathelicidin production were 3-times higher than those in African Americans [51]. In vitro supplementation of 25(OH)D3 to the African-American serum was able to restore cathelicidin expression to levels similar to the ones for Caucasians establishing that vitamin D deficiency compromises innate immune responses to infection [52]. The placenta is one of the first tissues shown to be capable of synthesizing 1,25 (OH)2D3 with 1a-hydroxylase receptor activity detected both in maternal decidua and fetal trophoblast [19]. The net effect is that vitamin D status can vary significantly in populations as a consequence of stress from social, behavioral and/or economic factors. Sensitivity of parathyroid hormone to the threshold of 80 nmol/l of 25(OH)D3 has led to re-evaluation of the optimal level up to 75 nmol/l are now considered to be inadequate and are more commonly referred to as vitamin D insufficiency as opposed to deficiency [53]. A newborn’s vitamin D stores are completely reliant on vitamin D from the mother [13]. Not surprisingly, poor maternal vitamin D status during pregnancy is a major risk factor for infant rickets [54]. This could be indicative of the fact that fetal programming is associated with the increased risk of common diseases in adult life. ×. Ï. Àðîðà, Ê. Äæ. Õîáåëü ³òàìè í D – íîâà ðîëü ïðè âàã³òíîñò³ Ðåçþìå ³òàì³í D ðå ãóëþº ðîçâè òîê ³ ôóíêö³þ ïëàöåíòè. Â³í º ïî òóæ íèì ðåãóëÿòîðîì ³ìóííî¿ ñèñòåìè, ùî ñòèìóëþº àíòèáàêòåð³éíó â³äïîâ³äü òà ïðè ãí³÷óº çàïàëåííÿ. Éîãî äåô³öèò ïðèçâîäèòü äî çðîñòàííÿ ðèçèêó ñåðéîçíèõ õðîí³÷íèõ ³ çàïàëüíèõ çàõâî ðþâàíü. Ïðî òÿ ãîì âàã³òíîñò³ äåô³öèò â³òàì³íó D ï³äâè ùóº ñïðèéíÿòëèâ³ñòü æ³íîê äî ³íôåêö³é ³ çàïàëåííÿ, ñïðè ÷è íÿº ïåðåä÷àñí³ ïîëîãè òà ïðå åêëàìïñ³þ. Âàã³òí³ æ³íêè ç òåìí³øîþ ï³ãìåíòàö³ºþ øê³ðè, ÿê³ æèâóòü ó ì³ñöÿõ ç íèç ü êèì ð³âíåì ñî íÿ÷íîãî ñâ³òëà, ÷àñò³øå ñòðàæ äà þòü â³ä äåô³öèòó â³òàì³íó D. Ïðè âàã³òíîñò³ ìîæëèâà àêòèâàö³ÿ ïåðâèííîãî íå³íôåêö³éíîãî çàïàëüíîãî ïðîöåñó âíàñë³äîê íåñòà÷³ â³òàì³íó D. Âè ÿâ ëåííÿ äåô³öèòó â³òàì³íó D ³ çà ïàëü íèõ ìàð êåð³â íà ð³çíèõ ñòàä³ÿõ âàã³òíîñò³ ìîæå ïîëåãøèòè ðîçï³çíàâàííÿ ðèçèêó áóäü-ÿêèõ óñêëàäíåíü. Êëþ ÷îâ³ ñëî âà: â³òàì³í D, âàã³òí³ñòü, ³ìóííà â³äïîâ³äü. VITAMIN D – A NOVEL ROLE IN PREGNANCY ×. Ï. Àðîðà, Ê. Äæ. Õîáåëü Âè òàìèí D – íîâàÿ ðîëü ïðè áå ðåìåí íîñòè Ðåçþìå Âèòàìèí D ðåãóëèðóåò ðàçâèòèå è ôóíêöèþ ïëàöåíòû. Îí ÿâ ëÿåòñÿ ìîùíûì ðåãóëÿòîðîì èììóííîé ñèñòåìû, ñòèìóëèðóÿ àíòèáàêòåðèàëüíûé îòâåò è ïîäàâëÿÿ âîñïàëåíèå. Åãî äåôè öèò ïðèâîäèò ê óâåëè÷åíèþ ðèñêà ñåðüåçíûõ õðîíè÷åñêèõ è âîñ ïàëèòåëüíûõ çàáîëåâàíèé. Âî âðåìÿ áåðåìåííîñòè äåôèöèò âèòàìèíà D óâåëè÷èâàåò âîñïðèèì÷èâîñòü æåíùèí ê èíôåêöèÿì è âîñïàëåíèþ, âûçûâàåò ïðåæäåâðåìåííûå ðîäû è ïðåýêëàìïñèþ. Áåðåìåííûå æåíùèíû ñ áîëåå òåìíîé ïèãìåíòàöèåé êîæè, æèâóùèå â îáëàñòÿõ ñ íèçêèì óðîâíåì ñîëíå÷íîãî ñâå òà, ÷àùå ïîäâåðæåíû äåôèöèòó âèòàìèíà D. Ïðè áåðåìåííîñòè âîçìîæíà àêòèâàöèÿ ïåðâè÷íîãî íåèíôåêöèîííîãî âîñïà ëèòåëüíîãî ïðîöåññà âñëåäñòâèå íåäîñòàòêà âèòàìèíà D. Âûÿâëåíèå äåôèöèòà âèòàìèíà D è âîñïàëèòåëüíûõ ìàðêåðîâ íà ðàçëè÷íûõ ñòàäèÿõ áåðåìåííîñòè ìîæåò îáëåã÷èòü ðàñïîçíàâàíèå ðèñêà âñåâîçìîæíûõ îñëîæíåíèé. Êëþ÷åâûå ñëîâà: âèòàìèí D, áåðåìåííîñòü, èììóííûé îò âåò. REFERENCES 1. Bodnar L. M., Simhan H. N., Powers R. W., Frank M. P., Cooperstein E., Roberts, J. M. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates // J. Nutr.– 2007.–137, N 2.–P. 447–452. 2. Holick M. F. Resurrection of vitamin D deficiency and rickets // J. Clin. Invest.–2006.–116, N 8.–P. 2062–2072. 3. Hollis B. W., Wagner C. L. Nutritional vitamin D status during pregnancy: reasons for concern // CMAJ Canad. Med. Assoc. J.–2006.–174, N 9.–P. 1287–1290. 4. Hollis B. W., Wagner C. L. Vitamin D deficiency during pregnancy: an ongoing epidemic // Amer. J. Clin. Nutr.–2006.– 84, N 2.–P. 273. 5. Chapuy M. C., Preziosi P., Maamer M., Arnaud S., Galan P., Hercberg S., Meunier P. J. Prevalence of vitamin D insufficiency in an adult normal population // Osteopor. Int.–1997.– 7, N 5.–P. 439–443. 6. Dawson-Hughes B., Heaney R. P., Holick M. F., Lips P., Meunier P. J., Vieth R. Estimates of optimal vitamin D status // Osteopor. Int.–2005.–16, N 7.–P. 713–716. 7. Stene L. C., Joner G., and Norwe gian Childhood Diabetes Study Group. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study // Am. J. Clin. Nutr.–2003.–78, N 6.–P. 1128–1134. 8. Camargo C. A. Jr., Rifas-Shiman S. L., Litonjua A. A., RichEdwards J. W., Weiss S. T., Gold D. R., Kleinman K., Gillman M. W. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age // Am. J. Clin. Nutr.–2007.–85, N 3.–P. 788–795. 9. McGrath J. Hy pothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? // Schizophr. Res.–1999.– 40, N 3.–P. 173–177. 10. McGrath J., Saari K., Hakko H., Jokelainen J., Jones P., Jarvelin M. R., Chant D., Isohanni M. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study // Schizophr. Res.–2004.–67, N 2– 3.–P. 237–245. 11. Evans K. N., Bulmer J. N., Kilby M. D., Hewison M. Vitamin D and placental-decidual function // J. Soc. Gynecol. In vest.– 2004.–11, N 5.–P. 263–271. 12. Romero R., Espinoza J., Goncalves L. F., Kusanovic J. P., Friel L. A., Nien J. K. Inflammation in preterm and term labour and delivery // Semin. Fe tal and Neonat. Med.–2006.–11, N 5.–P. 317–326. 13. Romero R., Espinoza J., Goncalves L. F., Kusanovic J. P., Friel L., Hassan S. The role of inflammation and infection in preterm birth // Semin. Reproduct. Med.–2007.–25, N 1.– P. 21–39. 14. Hillier S. L., Witkin S. S., Krohn M. A., Watts D. H., Kiviat N. B., Eschenbach D. A. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection // Obstet. and Gynecol.–1993.–81, N 6.–P. 941–948. 15. Gravett M. G., Novy M. J., Rosenfeld R. G., Reddy A. P., Jacob T., Turner M., McCormack A., Lapidus J. A., Hitti J., Eschenbach D. A., Rob erts C. T. Jr., Nagalla S. R. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers // JAMA.–2004.–292, N 4.– P. 462–469. 16. El-Shazly S., Makhseed M., Azizieh F., Raghupathy R. Increased expression of pro-inflammatory cytokines in placentas of women undergoing spontaneous preterm delivery or premature rupture of membranes // Am. J. Reprod. Immun.– 2004.–52, N 1.–P. 45–52. 17. Blank V., Hirsch E., Challis J. R., Romero R., Lye S. J. Cytokine signaling, inflammation, innate immunity and preterm labour – a workshop report // Placenta.–2008.–29, Suppl 1.– P. 102–104. 18. Gomez R., Romero R., Edwin S. S., David C. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection // Infect. Dis. Clin. North Amer.–1997.–11, N 1.–P. 135–176. 19. Fischer D., Schroer A., Ludders D., Cordes T., Bucker B., Reichrath J., Friedrich M. Metabo lism of vitamin D 3 in the placental tissue of normal and preeclampsia complicated pregnancies and premature births // Clin. Exp. Obstet. Gynecol.–2007.–34, N 2.–P. 80–84. 20. Diaz L., Arranz C., Avila E., Halhali A., Vilchis F., Larrea F. Ex pression and activity of 25-hydroxyvitamin D-1 alpha-hydroxylase are restricted in cultures of human syncytiotrophoblast cells from preeclamptic pregnancies // J. Clin. Endocrinol. Metabol.–2002.–87, N 8.–P. 3876–3882. 21. Hypponen E. Vitamin D for the prevention of preeclampsia? A hy pothesis // Nutr. Rev.–2005.–63, N 7.–P. 225–232. 22. Zehnder D., Evans K. N., Kilby M. D., Bulmer J. N., Innes B. A., Stewart P. M., Hewison M. The ontogeny of 25-hydroxyvitamin D(3) 1a-hydroxylase expression in human placenta and decidua // Am. J. Pathol.–2002.–161, N 1.–P. 105–114. 23. Nesby-O’Dell S., Scanlon K. S., Cogswell M. E., Gillespie C., Hollis B. W., Looker A. C., Allen C., Doughertly C., Gunter E. W., Bowman B. A. Hypovitaminosis D prev alence and determinants among African American and white women of reproductive age: third Nat. Health and Nutr. Ex amination Survey, 1988–1994 // Am. J. Clin. Nutr.–2002.–76, N 1.–P. 187–192. 24. Hollis B. W., Wagner C. L. Assessment of dietary vitamin D requirements during pregnancy and lactation // Amer. J. Clin. Nutr.–2004.–79, N 5.–P. 717–726. 103 CHANDER P. ARORA, HOBEL C. J. 25. Arora C. P., Hobel C. J. Vitamin D and IL-6 in pregnancies with subsequent preterm birth // Reprod. Sci.–2010.–17.– 179À–180À. Sage Publ. 26. Hobel C. J., Arora C. P., Adeniji A., Arora P., Jackman S. E., Miadel O., Baldiyan L. Circulating levels of vitamin D and IL-6 in pregnancies with IUGR // Reprod. Sci.–2008.–15, N 2, suppl.–121A–122A. Sage Publ. 27. Holick M. F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis // Am. J. Clin. Nutr.–2004.–79, N 3.–P. 362–371. 28. Clem ens T. L., Adams J. S., Henderson S. L., Holick M. F. Increased skin pigment reduces the capacity of skin to synthesise vitamin D 3 // Lancet.–1982.–319, N 8263.–P. 74–76. 29.Centers for Disease Control and Prevention (CDC). Differences in infant mortality between blacks and whites – United States, 1980–1991 // MMWR – Morbidity & Mortality Weekly Report.–1994.–43, N 16.–P. 288–289. 30. Arora C. P., Adeniji A., Jackman S. E., Forooghi B., Mostadim I., Yadegari P., Hobel C. J. Re duced plasma levels of vitamin D in Caucasian women at term are associated with increased rate of infection // Reprod. Sci.–2008.–15, N 2, suppl.–183A. Sage Publ. 31. Adeniji A., Arora C. P., Baldiyan L., Miadel O., Arora P., Ortega M., Le A., Koenig M., Hobel C. J. Reduced vitamin D levels in African American pregnancies are associated with increased rate of infection // Reprod. Sci.–2008.–15, N 2, suppl.–187A. Sage Publ. 32. Ev ans K. N., Nguyen L., Chan J., Innes B. A., Bulmer J. N., Kilby M. D., Hewison M. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells // Biol. Reprod.–2006.–75, N 6.–P. 816– 822. 33. Mathieu C. van, Etten E., Decallonne B., Guilietti A., Gysemans C., Bouillon R., Overbergh L. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system // J. Steroid Biochem. and Mol. Biol.–2004.–89–90, N 1–5.– P. 449–452. 34. Ad ams J. S., Liu P. T., Chun R., Modlin R. L., Hewison M. Vitamin D in defense of the human immune response // Ann. N. Y. Acad. Sci.–2007.–1117.–P. 94–105. 35. Liu H., Redline R. W., Han Y. W. Fusobacterium nucleatum induces fetal death in mice via stimulation of TLR4-mediated placental inflammatory response // J. Immunol.–2007.–179, N 4.–P. 2501–2508. 36. Cantorna M. T., Zhu Y., Froicu M., Wittke A. Vitamin D sta tus, 1,25-dihydroxyvitamin D3 , and the immune system // Am. J. Clin. Nutr.–2004.–80, N 6, suppl.–P. 1717S–1720S. 37. Griffin M. D., Xing N., Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation // Ann. Rev. Nutr.–2003.–23.–P. 117–145. 38. Deluca H. F., Cantorna M. T. Vitamin D: its role and uses in immunology // FASEB J.–2001.–15, N 14.–P. 2579–2585. 39. Townsend K., Ev ans K. N., Camp bell M. J., Colston K. W., Ad ams J. S., Hewison M. Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment // J. Steroid Biochem. and Mol. Biol.–2005.–97, N 1–2.–P. 103–109. 40. Hewison M., Zehnder D., Chakraverty R., Ad ams J. S. Vi tamin D and barrier function: a novel role for extra-renal 1 al- pha-hydroxylase // Mol. and Cell. Endocrinol.–2004.–215, N 1–2.–P. 31–38. 41. Kreutz M., Andreesen R., Krause S. W., Szabo A., Ritz E., Reichel H. 1,25-dihydroxyvitamin D3 production and vitamin D 3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages // Blood.–1993.–82, N 4.–P. 1300–1307. 42. Hewison M., Free man L., Hughes S. V., Evans K. N., Bland R., Eliopoulos A. G., Kilby M. D., Moss P. A., Chakraverty R. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells // J. Immunol.– 2003.–170, N 11.–P. 5382–5390. 43. Gray T. K., Lester G. E., Lorenc R. S. Evidence for extra-renal 1 alpha-hydroxylation of 25-hydroxyvitamin D3 in pregnancy // Science.–1979.–204, N 4399.–P. 1311–1313. 44. Weisman Y., Harell A., Edelstein S., Da vid M., Spirer Z., Golander A. 1 alpha, 25-Dihydroxyvitamin D 3 and 24,25-dihydroxyvitamin D3 in vi tro synthesis by human decidua and placenta // Nature.–1979.–281, N 5729.–P. 317–319. 45. Bruns M. E., Bruns D. E. Vitamin D metabolism and function during pregnancy and the neonatal period // Ann. Clin. Lab. Sci.–1983.–13, N 6.–P. 521–530. 46. Re but-Bonneton C., Demignon J. Effects of 1,25-dihydroxyvitamin D 3 on in vi tro lymphocyte reactions: arguments for a role at the maternofetal interface // Gynecol. Obstet. In vest.–1991.–32, N 3.–P. 134–138. 47. Sacks G., Sargent I., Redman C. An innate view of human pregnancy // Immunol. Today.–1999.–20, N 3.–P. 114–118. 48. Guleria I., Pollard J. W. The trophoblast is a component of the innate immune system during pregnancy // Nat. Med.– 2000.–6, N 5.–P. 589–593. 49. Zenclussen A. C., Schumacher A., Zenclussen M. L., Wafula P., Volk H. D. Immunology of pregnancy: cellular mechanisms allowing fetal survival within the maternal uterus // Expert Rev. Mol. Med.–2007.–9, N 10.–P. 1–14. 50. Laskarin G., Kammerer U., Rukavina D., Thomson A. W., Fernandez N., Blois S. M. Antigen-presenting cells and materno-fetal tolerance: an emerging role for dendritic cells // Am. J. Reprod. Immunol.–2007.–58, N 3.–P. 255–267. 51. Liu P. T., Stenger S., Li H., Wenzel L., Tan B. H., Krutzik S. R., Ochoa M. T., Schauber J., Wu K., Meinken C., Kamen D. L., Wag ner M., Bals R., Steinmeyer A., Zugel U., Gallo R. L., Eisenberg D., Hewison M., Hollis B. W., Adams J. S., Bloom B. R., Modlin R. L. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response // Science.– 2006.–311, N 5768.–P. 1770–1773. 52. Ad ams J. S., Hewison M. Unexpected actions of vitamin D: new per spectives on the regulation of innate and adaptive immunity // Nat. Clin. Pract. Endocrinol. Metabol.–2008.–4, N 2.–P. 80–90. 53. Bodnar L. M., Krohn M. A., Simhan H. N. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy // J. Nutr.–2009.–139, N 6.–P. 1157– 1161. 54. Fiscella K. Racial disparity in infant and maternal mortality: confluence of infection, and microvascular dysfunction // Matern. and Child Health J.–2004.–8, N 2.–P. 45–54. UDC 577.161.22; 618.2 Received 10.01.10 104 ")/,/'9 #ELL $EFENSES AND THE 6ITAMIN 3CIENTISTS NOW RECOGNIZE THAT VITAMIN $ DOES MUCH MORE THAN BUILD STRONG BONES AND THAT MANY PEOPLE ARE NOT GETTING ENOUGH OF IT )S WIDESPREAD $ DElCIENCY CONTRIBUTING TO MAJOR ILLNESSES +%9 #/.#%043 N N N 6ITAMIN $ LONG ASSOCIATED ONLY WITH ITS ROLE IN BONE FORMATION IS ACTUALLY ACTIVE THROUGHOUT THE HUMAN BODY POWERFULLY IN mUENCING IMMUNE SYSTEM RE SPONSES AND CELL DEFENSES )T CAN BE OBTAINED FROM FOOD OR MANUFACTURED BY HUMAN SKIN EXPOSED TO SUNLIGHT -EASURES OF VITAMIN $ LEVELS SHOW HOW EVER THAT MANY PEOPLE HAVE TOO LITTLE OF IT CIRCULATING IN THEIR BLOOD TO PROTECT HEALTH #LEAR ASSOCIATIONS BETWEEN LOW VITAMIN $ LEVELS AND CANCERS AUTOIMMUNITY INFECTIOUS DIS EASES AND OTHER CONDITIONS SUG GEST THAT CURRENT DAILY INTAKE RECOMMENDATIONS FOR THIS CRITI CAL NUTRIENT NEED REVISION ÅI]Z:Y^idgh +' 3 # ) % . 4 ) & ) # ! - % 2 ) # ! . ) ÌÊÜ>ÃÊV>i`ÊÌ iÊÃ՘à ˆ˜iÊVÕÀi]Ê>˜`ʈ˜Ê Ì iÊi>ÀÞÊÓäÌ ÊVi˜ÌÕÀÞ]ÊLivœÀiÊÌ iÊiÀ>Ê œvÊ>˜ÌˆLˆœÌˆVÃ]ʈÌÊÜ>ÃÊÌ iʜ˜ÞÊivviV̈ÛiÊ Ì iÀ>«ÞÊvœÀÊÌÕLiÀVՏœÃˆÃʎ˜œÜ˜°Ê œÊœ˜iÊ Ž˜iÜÊÜ ÞʈÌÊܜÀŽi`]ʍÕÃÌÊÌ >ÌÊ/ Ê«>̈i˜ÌÃÊ Ãi˜ÌÊ̜ÊÀiÃÌʈ˜ÊÃ՘˜ÞʏœV>iÃÊÜiÀiʜvÌi˜Ê ÀiÃ̜Ài`ÊÌœÊ i>Ì °Ê/ iÊÃ>“iʺÌÀi>̓i˜Ì»Ê >`ÊLii˜Ê`ˆÃVœÛiÀi`ʈ˜Ê£nÓÓÊvœÀÊ>˜œÌ iÀÊ ˆÃ̜ÀˆVÊ ÃVœÕÀ}i]Ê ÀˆVŽiÌà p >Ê `ivœÀ“ˆ˜}Ê V ˆ` œœ`ÊVœ˜`ˆÌˆœ˜ÊV>ÕÃi`ÊLÞÊ>˜Êˆ˜>Lˆ‡ ˆÌÞÊ̜ʓ>ŽiÊ >À`i˜i`ÊLœ˜i°Ê,ˆVŽiÌÃÊ >`Ê Lii˜Êœ˜ÊÌ iÊÀˆÃiʈ˜Ê£nÌ ‡Ê>˜`Ê£™Ì ‡Vi˜ÌÕÀÞÊ ÕÀœ«i]ÊVœˆ˜Vˆ`ˆ˜}ÊÜˆÌ Êˆ˜`ÕÃÌÀˆ>ˆâ>̈œ˜Ê >˜`Ê Ì iÊ “œÛi“i˜ÌÊ œvÊ «iœ«iÊ vÀœ“Ê Ì iÊ VœÕ˜ÌÀÞÈ`iÊ̜ÊÌ iÊ«œÕÌi`ÊVˆÌˆiÃ]ÊÜ i˜Ê>Ê 7>ÀÃ>ÜÊ`œV̜ÀʜLÃiÀÛi`ÊÌ >ÌÊÌ iÊ«ÀœLi“Ê Ü>ÃÊÀi>̈ÛiÞÊÀ>Àiʈ˜ÊÀÕÀ>Ê*œˆÃ ÊV ˆ`Ài˜°Ê iÊLi}>˜ÊiÝ«iÀˆ“i˜Ìˆ˜}ÊÜˆÌ ÊVˆÌÞÊV ˆ‡ `Ài˜Ê>˜`ÊvœÕ˜`ÊÌ >ÌÊ iÊVœÕ`ÊVÕÀiÊÌ iˆÀÊ ÀˆVŽiÌÃÊÜˆÌ ÊiÝ«œÃÕÀiÊ̜ÊÃ՘à ˆ˜iÊ>œ˜i°Ê ÞÊ£nÓ{ÊiÀ“>˜ÊÃVˆi˜ÌˆÃÌÃÊvœÕ˜`ÊÌ >ÌÊ Vœ`‡ˆÛiÀʜˆÊ>ÃœÊ >`ÊiÝVii˜ÌÊ>˜ÌˆÀˆVŽiÌÃÊ «Àœ«iÀ̈iÃ]Ê>Ì œÕ} ÊÌ >ÌÊÌÀi>̓i˜ÌÊ`ˆ`Ê ˜œÌÊV>ÌV ʜ˜Ê܈`iÞ]ʈ˜Ê«>ÀÌÊLiV>ÕÃiÊÌ iÊ «œÃÈLˆˆÌÞÊÌ >ÌÊ>Êvœœ`ʓˆ} ÌÊVœ˜Ì>ˆ˜Ê՘‡ "*9,/ÊÓääÇÊ-  Ãii˜Ê“ˆVÀœ˜ÕÌÀˆi˜ÌÃʈ“«œÀÌ>˜ÌÊÌœÊ i>Ì Ê Ü>ÃʘœÌÊÞiÌÊ՘`iÀÃ̜œ`ÊLÞÊ`œV̜Àðʘ`Ê ˜i>ÀÞÊ>ÊVi˜ÌÕÀÞÊܜՏ`Ê«>ÃÃÊLivœÀiÊÃVˆi˜‡ ̈ÃÌÃʓ>`iÊÌ iÊVœ˜˜iV̈œ˜ÊLiÌÜii˜ÊÃÕV Ê `ˆiÌ>ÀÞÊVÕÀiÃÊvœÀÊÀˆVŽiÌÃÊ>˜`ÊÌ iÊLi˜iwVˆ>Ê ivviVÌÃʜvÊÃ՘à ˆ˜i°Ê >ÀÞÊÓäÌ ‡Vi˜ÌÕÀÞÊÀi‡ Ãi>ÀV iÀÃÊ Ã œÜi`Ê Ì >ÌÊ ˆÀÀ>`ˆ>Ìi`Ê ÃŽˆ˜]Ê Ü i˜Êvi`Ê̜ÊÀ>ÌÃÊÜˆÌ Ê>À̈wVˆ>Þʈ˜`ÕVi`Ê ÀˆVŽiÌÃ]Ê >`ÊÌ iÊÃ>“iÊVÕÀ>̈ÛiÊ«Àœ«iÀ̈iÃÊ >ÃÊVœ`‡ˆÛiÀʜˆ°Ê/ iÊVÀˆÌˆV>ÊVœ““œ˜Êii‡ “i˜Ìʈ˜ÊÌ iÊΈ˜Ê>˜`ÊÌ iʜˆÊÜ>ÃÊw˜>ÞÊ ˆ`i˜Ìˆwi`ʈ˜Ê£™ÓÓÊ>˜`Ê`ÕLLi`ÊۈÌ>“ˆ˜Ê °Ê ÞÊÌ i˜ÊÌ iʈ`i>ʜvʺۈÌ>Ê>“ˆ˜iÃ]»ÊœÀÊۈÌ>‡ “ˆ˜Ã]ÊÜ>ÃÊ>Ê«œ«Õ>ÀʘiÜÊÃVˆi˜ÌˆwVÊ̜«ˆV]Ê >˜`ÊÃÕLÃiµÕi˜ÌÊÀiÃi>ÀV ʈ˜ÌœÊÌ iÊv՘V‡ ̈œ˜ÃʜvÊۈÌ>“ˆ˜Ê ʈ˜ÊÌ iÊLœ`ÞÊÜ>ÃÊÛiÀÞÊ “ÕV Êà >«i`ÊLÞÊ ½Ãʈ“>}iÊ>Ãʜ˜iʜvÊÌ œÃiÊ iÃÃi˜Ìˆ>Ê“ˆVÀœ˜ÕÌÀˆi˜ÌÃÊÌ >ÌÊ Õ“>˜ÃÊV>˜Ê œLÌ>ˆ˜Êœ˜ÞÊvÀœ“Êvœœ`° / iÊ>ÃÜVˆ>̈œ˜ÊÜˆÌ ÊÀˆVŽiÌÃÊ>ÃœÊÃÌiiÀi`Ê “œÃÌÊۈÌ>“ˆ˜Ê ÊÀiÃi>ÀV ÊvœÀÊÌ iʘiÝÌÊxäÊ Þi>ÀÃÊ̜Ü>À`Ê՘`iÀÃÌ>˜`ˆ˜}ÊÌ iʓœiVՏi½ÃÊ Àœiʈ˜ÊLœ˜iÊLՈ`ˆ˜}Ê>˜`Ê œÜʈÌÊ>VÌÃʈ˜ÊÌ iÊ Žˆ`˜iÞÃ]ʈ˜ÌiÃ̈˜iÃÊ>˜`ÊÌ iÊÎii̜˜ÊˆÌÃivÊÌœÊ i«ÊVœ˜ÌÀœÊÌ iÊyœÜʜvÊV>VˆÕ“ʈ˜ÌœÊ>˜`Ê / Ê ,  ]Ê ° .OVEMBER   *!-%3 #2%$)40/24/ "Y ,UZ % 4AVERA -ENDOZA AND *OHN ( 7HITE #2%$)4 W W W 3 C I ! M  C O M "*9,/ÊÓääÇÊ-  / Ê ,  ]Ê ° 3#)%.4)&)# !-%2)#!.  +( ;4(% "!3)#3= 4(% -!+).' /& !. !#4)6% 6)4!-). 4HE TERM hVITAMIN $v REFERS TO TWO SLIGHTLY DIFFERENT MOLECULES ˆ $ MANUFACTURED BY HUMAN SKIN AND $ WHICH ORIGINATES IN PLANTS AND WHICH PEOPLE CAN OBTAIN FROM FOOD "OTH VERSIONS OF $ MUST UNDERGO STAGES OF CONVERSION BY ENZYMES TO REACH A BIOLOGICALLY ACTIVE FORM KNOWN AS  $ 6)4!-). $ &2/- &//$ 6)4!-). $ -!$% "9 (5-!. 3+). 5LTRAVIOLET " LIGHT IS $ $ %PIDERM 56" LIGHT  DEHYDROCHOLESTEROL  6ITAMIN $ IS MADE BY SKIN CELLS CALLED KERATINOCYTES WHEN ULTRAVIOLET L " LIGHT AND HEAT ACT ON A BREAKDOWN PRODUCT OF CHOLESTEROL  $ERMIS  4O CIRCULATION +ERATINOCYTES -ELANOCYTE ,)6%2 $ OR $ DEHYDROCHOLESTEROL   6ITAMIN $ FOUND IN CERTAIN FOODS IS DERIVED FROM A SIMILAR PLANT STEROL MOLECULE   7HETHER MANUFACTURED IN THE SKIN OR INGESTED BOTH $ AND $ ENTER THE CIRCULATORY SYSTEM %NZYME  7HEN CIRCULATING $ OR $ REACHES THE L LIVER IT IS CHEMICALLY CONVERTED BY ENZYMES  INTO  HYDROXYVITAMIN $ $  4HE $ FORM OF THE VITAMIN THEN REENTERS THE CIRCULATION ,/#!, !#4)6!4)/. 3KIN IS THE ONLY TISSUE IN THE HUMAN BODY THAT CAN MANUFACTURE $ AS WELL AS ALL THE ENZYMES NEEDED TO CONVERT $ INTO $ AND THEN INTO  $ )MMUNE CELLS AND SEVERAL OTHER TISSUES CAN MAKE THE ENZYME NEEDED TO CONVERT $ INTO  $ LOCALLY %NZYME  $ +)$.%9 4O CIRCULATION %NZYME $ %NZYME $  $  -UCH OF THE BODYS CIRCULATING $ L UNDERGOES A lNAL TRANSFORMATION IN THE KIDNEYS WHERE ENZYMES CONVERT $ INTO  $ WHICH IS RELEASED TO THE CIRCULATION AND TRAVELS TO THE MANY DIFFERENT ORGANS AND CELL TYPES WHERE VITAMIN $ AFFECTS PHYSIOLOGY œÕÌʜvÊLœ˜iÃÊvÀœ“ÊÌ iÊLœœ`ÃÌÀi>“°Ê˜ÊÌ iÊ«>ÃÌÊ µÕ>ÀÌiÀÊVi˜ÌÕÀÞ]Ê œÜiÛiÀ]ÊÃÌÕ`ˆiÃʜvÊۈÌ>“ˆ˜Ê ½ÃÊ v՘V̈œ˜Ê >ÛiÊLÀœ>`i˜i`]ÊÀiÛi>ˆ˜}ÊÌ >ÌÊÌ iÊ܇ V>i`ÊÃ՘à ˆ˜iÊۈÌ>“ˆ˜Ê`œiÃÊv>ÀʓœÀiÊÌ >˜ÊLՈ`Ê Lœ˜iÃ°Ê ÝÌi˜ÃˆÛiÊiۈ`i˜ViʘœÜÊà œÜÃÊÌ >ÌÊ Ê >ÃÊ «œÌi˜ÌÊ>˜ÌˆV>˜ViÀÊ>V̈œ˜ÃÊ>˜`Ê>ÃœÊÃiÀÛiÃÊ>ÃÊ>˜Ê ˆ“«œÀÌ>˜ÌÊÀi}Տ>̜Àʜvʈ““Õ˜iÊÃÞÃÌi“ÊÀi뜘Ç iðÊœÀiœÛiÀ]ʓ>˜ÞʜvÊ ½Ãʘi܏ÞÊÀiVœ}˜ˆâi`ÊLi˜‡ iwÌÃÊ>Àiʓ>݈“ˆâi`ÊÜ i˜ÊˆÌʈÃÊ«ÀiÃi˜Ìʈ˜ÊÌ iÊ Lœœ`ÃÌÀi>“Ê>ÌʏiÛiÃÊVœ˜Ãˆ`iÀ>LÞÊ ˆ} iÀÊÌ >˜Ê Ì œÃiÊvœÕ˜`ʈ˜Ê“>˜ÞÊ«œ«Õ>̈œ˜Ã°Ê/ iÃiÊw˜`ˆ˜}Ã]Ê Ìœ}iÌ iÀÊÜˆÌ Êi«ˆ`i“ˆœœ}ˆV>Ê`>Ì>ʏˆ˜Žˆ˜}ʏœÜÊ ÛˆÌ>“ˆ˜Ê ʏiÛiÃÊ̜Ê`ˆÃi>Ãi]ÊÃÕ««œÀÌÊÌ iÊ«œÃÈLˆ‡ ˆÌÞÊÌ >ÌÊ܈`iëÀi>`ÊۈÌ>“ˆ˜Ê Ê`iwVˆi˜VÞʈÃÊVœ˜‡ ÌÀˆLṎ˜}Ê̜Ê>ʘՓLiÀʜvÊÃiÀˆœÕÃʈ˜iÃÃiÃ°Ê +) 3 # ) % . 4 ) & ) # ! - % 2 ) # ! . "*9,/ÊÓääÇÊ-  4O CIRCULATION ! 6ERSATILE 3WITCH /œÊ“>ŽiÊÃi˜ÃiʜvʘiÜÊw˜`ˆ˜}ÃÊ>LœÕÌÊۈÌ>“ˆ˜Ê ]Ê ˆÌÊ«>ÞÃÊ̜ÊwÀÃÌÊÀiۈiÜÊÜ >ÌÊ Ê>VÌÕ>ÞʈÃÊ>˜`Ê œÜÊ ˆÌʈÃÊÕÃi`ʈ˜ÊÌ iÊ Õ“>˜ÊLœ`Þ°Ê*iœ«iÊV>˜ÊœLÌ>ˆ˜Ê Ì iʓœiVՏiʎ˜œÜ˜Ê>ÃÊۈÌ>“ˆ˜Ê ÊvÀœ“ʏˆ“ˆÌi`Ê vœœ`ÊÜÕÀViÃ]ÊÃÕV Ê>ÃÊv>ÌÌÞÊwà Ê>˜`Êwà ʜˆ]Ê>˜`]Ê Ìœ`>Þ]ÊvÀœ“Ê`ˆiÌ>ÀÞÊÃÕ««i“i˜ÌÃ°Ê ÕÌÊÜiÊV>˜Ê >ÃœÊ“>ŽiʈÌʜÕÀÃiÛiÃ]ÊÌ ÀœÕ} Ê>ÊV i“ˆV>ÊÀi>V‡ ̈œ˜ÊÌ >ÌÊ >««i˜Ãʈ˜ÊÌ iÊΈ˜ÊÜ i˜ÊˆÌʈÃÊiÝ«œÃi`Ê ÌœÊՏÌÀ>ۈœiÌÊ Ê­16 ®Êˆ} Ì°Ê-ÌÀˆV̏ÞÊëi>Žˆ˜}]Ê Ì i˜]ÊۈÌ>“ˆ˜Ê ʈÃʘœÌÊ>ÊۈÌ>“ˆ˜Ê>ÌÊ>]ÊLiV>ÕÃiÊ ÜˆÌ Ê“œ`iÀ>ÌiÊ16 ÊiÝ«œÃÕÀi]ÊÜiÊ`œÊ˜œÌʘii`Ê ÌœÊ}iÌʈÌÊvÀœ“Êvœœ`°Ê˜ÊÌi“«iÀ>ÌiÊÀi}ˆœ˜ÃʜvÊÌ iÊ ÜœÀ`]Ê œÜiÛiÀ]Ê16 ʏˆ} ÌʈÃʈ˜ÃÕvwVˆi˜ÌÊÌœÊ ˆ˜`ÕViÊ>`iµÕ>ÌiÊۈÌ>“ˆ˜Ê ÊÃÞ˜Ì iÈÃʈ˜ÊÌ iÊΈ˜Ê / Ê ,  ]Ê ° .OVEMBER   !.$2%7 37)&4 $  *!-%3 0/24/ vœÀÊÕ«Ê̜ÊÈÝʓœ˜Ì ÃʜvÊÌ iÊÞi>À]Ê>˜`ÊÌ i˜Ê`ˆiÌ>ÀÞÊ ÃœÕÀViÃʜvÊۈÌ>“ˆ˜Ê ÊLiVœ“iÊiÃÃi˜Ìˆ>ÊQÃiiÊLœÝÊ œ˜Êœ««œÃˆÌiÊ«>}iR°Ê / iÊÌiÀ“ʺۈÌ>“ˆ˜Ê »Ê}i˜iÀ>ÞÊÀiviÀÃÊVœiV‡ ̈ÛiÞÊ̜ÊÌ iÊÌܜÊÛiÀÞÊȓˆ>ÀʓœiVՏiÃÊÌ >ÌÊ Vœ“iÊvÀœ“Êi>V ʜvÊÌ œÃiÊÜÕÀViðÊ6ˆÌ>“ˆ˜Ê Î]Ê Ü ˆV ʈÃÊ>ÃœÊŽ˜œÜ˜Ê>ÃÊV œiV>VˆviÀœ]ʈÃÊVÀi>̇ i`ÊLÞÊΈ˜ÊViÃÊV>i`ʎiÀ>̈˜œVÞÌiÃÊvÀœ“Ê>Ê LÀi>Ž`œÜ˜Ê«Àœ`ÕVÌʜvÊV œiÃÌiÀœ]ÊLJ`i Þ`Àœ‡ V œiÃÌiÀœ]ʈ˜ÊÀi뜘ÃiÊ̜Ê16 ʏˆ} Ì°Ê6ˆÌ>“ˆ˜Ê Ó ]ʜÀÊiÀ}œV>VˆviÀœ]ʈÃÊ`iÀˆÛi`ÊvÀœ“Ê>Êȓˆ>ÀÊ «>˜ÌÊÃÌiÀœ]Ê>˜`ÊÌ iÊÀiÃՏ̈˜}ʓœiVՏiÊ >ÃÊ Ãˆ} ÌÊÃÌÀÕVÌÕÀ>Ê`ˆvviÀi˜ViÃÊÌ >ÌÊ`ˆÃ̈˜}Ոà ʈÌÊ vÀœ“Ê Î°Ê iˆÌ iÀÊÛiÀȜ˜Ê >ÃÊ>˜ÞÊLˆœœ}ˆV>Ê>V‡ ̈ۈÌÞʈ˜ÊÌ iÊLœ`Þ]Ê œÜiÛiÀ°ÊˆÀÃÌ]ÊiˆÌ iÀʓœi‡ VՏiʓÕÃÌÊLiʓœ`ˆwi`ÊLÞÊ>ÊÃiÀˆiÃʜvÊÀi>Ìi`Êi˜‡ âޓiÃʈ˜Ê>Ê«ÀœViÃÃÊV>i`Ê Þ`ÀœÝޏ>̈œ˜]ÊÜ ˆV Ê >``ÃÊÌܜÊÌ ˆÀ`ÃʜvÊ>ÊÜ>ÌiÀʓœiVՏiÊ̜Ê}i˜iÀ>ÌiÊ Óx‡ Þ`ÀœÝÞۈÌ>“ˆ˜Ê Ê­Óx ®°Ê / >ÌÊVœ˜ÛiÀȜ˜ÊÌ>ŽiÃÊ«>ViÊ«Àˆ“>ÀˆÞʈ˜ÊÌ iÊ ˆÛiÀ]ÊLÕÌÊÛ>ÀˆœÕÃÊViÊÌÞ«iÃÊÜˆÌ ˆ˜ÊÌ iÊΈ˜Ê>ÀiÊ >ÃœÊV>«>LiʜvÊ«iÀvœÀ“ˆ˜}ÊÌ iÊÌÀ>˜ÃvœÀ“>̈œ˜Ê œV>Þ°Ê/ iÊÓx ʓ>`iÊLÞÊÌ iʏˆÛiÀʈÃʘœ˜iÌ iiÃÃÊ Ì iʓ>œÀÊvœÀ“ÊœvÊۈÌ>“ˆ˜Ê ÊVˆÀVՏ>̈˜}ʈ˜ÊÌ iÊ Lœœ`ÃÌÀi>“°Ê7 i˜ÊˆÌʈÃʘii`i`ʈ˜ÊÌ iÊLœ`Þ]Ê>Êw‡ ˜>ÊVœ˜ÛiÀȜ˜Ê̜ÊÌ iÊLˆœœ}ˆV>ÞÊ>V̈ÛiÊvœÀ“ʈÃÊ ÀiµÕˆÀi`p Óx ʈÃÊvÕÀÌ iÀÊ Þ`ÀœÝޏ>Ìi`Ê>˜`ÊLi‡ Vœ“iÃÊ£]Óx‡`ˆ Þ`ÀœÝÞۈÌ>“ˆ˜Ê Ê­£]Óx ®°Ê/ iÊ i˜âޓiÊÌ >ÌÊ«iÀvœÀ“ÃÊÌ ˆÃÊÌ>Î]Ê£>« >‡ Þ`ÀœÝ‡ ޏ>Ãi]ÊÜ>ÃÊwÀÃÌÊ`ˆÃVœÛiÀi`ʈ˜ÊÌ iʎˆ`˜iÞ]Ê>˜`ÊÀi‡ ˜>Ê «ÀœViÃȘ}Ê ˆÃÊ Ài뜘ÈLiÊ vœÀÊ }i˜iÀ>̈˜}Ê “ÕV ʜvÊÌ iÊLœ`Þ½ÃÊVˆÀVՏ>̈˜}Ê£]Óx ÊÃÕ««Þ°Ê "˜ViÊ>}>ˆ˜]Ê œÜiÛiÀ]ÊÃVˆi˜ÌˆÃÌÃʘœÜÊÀi>ˆâiÊ Ì >Ìʓ>˜ÞÊœÌ iÀÊ̈ÃÃÕiÃ]ʈ˜VÕ`ˆ˜}ÊViÃʜvÊÌ iÊ ˆ““Õ˜iÊÃÞÃÌi“Ê>˜`ÊÌ iÊΈ˜]ÊV>˜Ê>ÃœÊ“>ŽiÊÌ >ÌÊ i˜âޓiÊ>˜`Ê«iÀvœÀ“ÊÌ iÊÓx ÊVœ˜ÛiÀȜ˜ÊÌ i“‡ ÃiÛiðÊ-Žˆ˜ÊˆÃÊÌ iÀivœÀiÊ՘ˆµÕiÊ>“œ˜}ʜÀ}>˜Ãʈ˜Ê Ì >ÌʈÌʈÃÊV>«>Liʜvʓ>˜Õv>VÌÕÀˆ˜}ÊLˆœœ}ˆV>ÞÊ >V̈ÛiÊ£]Óx ʈ˜ÊÌ iÊ«ÀiÃi˜ViʜvÊ16 ʏˆ} ÌÊvÀœ“Ê ÃÌ>ÀÌÊ̜Êvˆ˜ˆÃ ]Ê>Ì œÕ} ʏœV>Ê«Àœ`ÕV̈œ˜ÊœvÊ £]Óx ÊvÀœ“ÊVˆÀVՏ>̈˜}ÊÓx ʈ˜ÊœÌ iÀÊ̈ÃÃÕiÃʈÃÊ>Ê ÃÕLÃÌ>˜Ìˆ>ÊÜÕÀViʜvÊۈÌ>“ˆ˜Ê ½ÃÊLˆœœ}ˆV>Ê>V‡ ̈ۈÌÞʈ˜ÊÌ iÊLœ`ÞÊÌ >ÌÊÜ>ÃʘœÌÊ>««ÀiVˆ>Ìi`Ê՘̈Ê ÛiÀÞÊÀiVi˜ÌÞ°Ê"˜ViÊÌ iÊLÀi>`Ì ÊœvÊ ½ÃÊ>V̈ۈÌÞʈÃÊ Vœ˜Ãˆ`iÀi`]ÊÌ œÕ} ]ʈÌÊLiVœ“iÃÊi>ÃÞÊ̜ÊÃiiÊÜ ÞÊ Ì iÊ>LˆˆÌÞÊ̜ʓ>ŽiʈÌÃÊ>V̈ÛiÊvœÀ“ÊvœÀʏœV>ÊÕÃiÊ “ˆ} ÌÊLiʈ“«œÀÌ>˜ÌÊ̜ÊViÀÌ>ˆ˜ÊÌÞ«iÃʜvÊViÃ°Ê / iÊ£]Óx ʓœiVՏiÊv՘V̈œ˜ÃÊ>ÃÊ>ÊÃ܈ÌV Ê Ì >ÌÊV>˜ÊÌÕÀ˜Ê}i˜iÃʺœ˜»ÊœÀʺœvv»Êˆ˜ÊۈÀÌÕ>ÞÊ iÛiÀÞÊ̈ÃÃÕiʈ˜ÊÌ iÊ Õ“>˜ÊLœ`Þ°Ê/ ˆÃÊvœÀ“ÊœvÊ Ê >VÌÃÊLÞÊ>ÌÌ>V ˆ˜}Ê̜Ê>Ê«ÀœÌiˆ˜ÊŽ˜œÜ˜Ê>ÃÊÌ iÊۈ‡ Ì>“ˆ˜Ê ÊÀiVi«ÌœÀÊ­6 ,®]ÊÜ ˆV ÊÃiÀÛiÃÊ>ÃÊ>Ê܇ V>i`ÊÌÀ>˜ÃVÀˆ«Ìˆœ˜Êv>V̜Àʈ˜Ãˆ`iÊ>ÊVi½ÃʘÕViÕÃ°Ê "˜ViÊLœÕ˜`ÊLÞÊ£]Óx ]ÊÌ iÊ6 ,Ê«ÀœÌiˆ˜ÊÃiiŽÃÊ œÕÌÊ>ÊVœ“«>˜ˆœ˜Ê«ÀœÌiˆ˜]ÊÌ iÊÀˆ`‡ÝÊÀiVi«‡ W W W 3 C I ! M  C O M ̜ÀÊ­,8,®]Ê>˜`ÊÌ iÊVœ“«iÝÊÌ iÞÊvœÀ“ÊLˆ˜`ÃÊÌœÊ >ÊëiVˆwVÊÀi}ˆœ˜ÊœvÊÌ iÊVi½ÃÊ Ê>`>Vi˜ÌÊ̜Ê>Ê Ì>À}iÌÊ}i˜i°Ê/ iˆÀÊ>ÌÌ>V “i˜ÌÊ̜ÊÌ iÊ ʈ˜‡ `ÕViÃÊViÕ>Àʓ>V ˆ˜iÀÞÊ̜ÊLi}ˆ˜ÊÌÀ>˜ÃVÀˆLˆ˜}Ê Ì iʘi>ÀLÞÊ}i˜iʈ˜ÌœÊ>ÊvœÀ“ÊÌ >ÌÊÌ iÊViÊ܈Ê ÌÀ>˜Ã>Ìiʈ˜ÌœÊ>Ê«ÀœÌiˆ˜ÊQÃiiÊLœÝʜ˜Ê«>}iÊÈnR°Ê ÞÊV>ÕȘ}Ê>ÊViÊ̜ʓ>ŽiÊ>Ê«>À̈VՏ>ÀÊ«ÀœÌiˆ˜]Ê £]Óx Ê>ÌiÀÃÊViÕ>ÀÊv՘V̈œ˜]Ê>˜`ÊÌ ˆÃÊ>LˆˆÌÞÊ ÌœÊÌÀˆ}}iÀÊ}i˜iÊ>V̈ۈÌÞʈ˜Ê`ˆvviÀi˜ÌÊViÃʈÃÊÌ iÊ L>ÈÃʜvÊۈÌ>“ˆ˜Ê ½ÃÊ܈`iëÀi>`Ê« ÞȜœ}ˆV>Ê ivviVÌÃ°Ê iV>ÕÃiÊ ÊˆÃÊ>ÊÃÕLÃÌ>˜Viʓ>˜Õv>VÌÕÀi`Ê ˆ˜Êœ˜iÊ̈ÃÃÕiÊ>˜`ÊVˆÀVՏ>ÌiÃÊÌ ÀœÕ} ÊÌ iÊLœ`Þʈ˜‡ yÕi˜Vˆ˜}ʓ>˜ÞÊœÌ iÀÊ̈ÃÃÕiÃ]ʈÌʈÃÊ>ÃœÊÌiV ˜ˆ‡ V>ÞÊ>Ê œÀ“œ˜i°Ê˜Êv>VÌ]ÊÌ iÊ6 ,ÊLiœ˜}ÃÊ̜Ê>Ê v>“ˆÞʜvÊ«ÀœÌiˆ˜Ãʎ˜œÜ˜Ê>ÃʘÕVi>ÀÊÀiVi«ÌœÀÃÊ Ì >ÌÊÀi뜘`Ê̜ʫœÜiÀvՏÊÃÌiÀœˆ`>Ê œÀ“œ˜iÃÊ ÃÕV Ê>ÃÊiÃÌÀœ}i˜Ê>˜`ÊÌiÃ̜ÃÌiÀœ˜i° Ìʏi>ÃÌÊ£]äääÊ`ˆvviÀi˜ÌÊ}i˜iÃÊ>ÀiÊLiˆiÛi`ÊÌœÊ LiÊÀi}Տ>Ìi`ÊLÞÊ£]Óx ]ʈ˜VÕ`ˆ˜}ÊÃiÛiÀ>Êˆ˜‡ ۜÛi`ʈ˜ÊÌ iÊLœ`Þ½ÃÊV>VˆÕ“Ê«ÀœViÃȘ}ÊÌ >ÌÊ>V‡ VœÕ˜ÌÊvœÀÊ ½ÃÊÜi‡Ž˜œÜ˜ÊÀœiʈ˜ÊLœ˜iÊvœÀ“>‡ 3/52#%3 /& ̈œ˜°Ê"ÛiÀÊÌ iÊ«>ÃÌÊÌܜÊ`iV>`iÃ]Ê œÜiÛiÀ]ÊÃVˆ‡ 6)4!-). $ i˜ÌˆÃÌÃÊ >ÛiÊ ˆ`i˜Ìˆvˆi`Ê “>˜ÞÊ œÌ iÀÊ }i˜iÃÊ ˆ˜yÕi˜Vi`ÊLÞÊۈÌ>“ˆ˜Ê Ê>V̈ۈÌÞʈ˜ÊÌ iÊLœ`Þ]ʈ˜‡ 6ITAMINS $ AND $ OCCUR NATURAL VÕ`ˆ˜}Ê}i˜iÃÊÜˆÌ ÊVÀˆÌˆV>ÊÀœiÃʈ˜Ê>ÊÛ>ÀˆiÌÞʜvÊ LY IN SOME FOODS AND BOTH VER SIONS OF THE VITAMIN ARE ADDED TO ViÕ>ÀÊ`ivi˜ÃiÃ°Ê &ORTIFICATION BY $ -ˆ˜ViÊÌ iÊ£™näÃÊÛ>ÀˆœÕÃʏˆ˜iÃʜvÊiۈ`i˜ViÊ >ÛiÊ «œˆ˜Ìi`Ê̜ÊۈÌ>“ˆ˜Ê ½ÃÊ«ÀœÌiV̈ÛiÊivviVÌÊ>}>ˆ˜ÃÌÊ V>˜ViÀ°Ê >˜ÞÊ i«ˆ`i“ˆœœ}ˆV>Ê ÃÌÕ`ˆiÃÊ >ÛiÊ Ã œÜ˜Ê>ÊÃÌÀœ˜}ʈ˜ÛiÀÃiÊÀi>̈œ˜ÊLiÌÜii˜ÊiÝ«œ‡ ÃÕÀiÊ̜ÊÃ՘ˆ} ÌÊ>˜`ÊÌ iʈ˜Vˆ`i˜ViʜvÊViÀÌ>ˆ˜Ê ÌÞ«iÃʜvÊV>˜ViÀ°Ê-ÌÕ`ˆiÃʈ˜Ê>˜ˆ“>ÃÊ>˜`ÊViÊVՏ‡ ÌÕÀiÃÊ >ÛiÊÃÕ««œÀÌi`ÊÌ >ÌÊ>ÃÜVˆ>̈œ˜Ê>˜`Ê i«i`Ê ÌœÊ «ˆ˜«œˆ˜ÌÊ Ì iÊ “iV >˜ˆÃ“ÃÊ Ì >ÌÊ “>ÞÊ LiÊ ˆ˜ÛœÛi`°Ê ˜Ê>ʓœÕÃiʓœ`iÊœvÊ i>`Ê>˜`ʘiVŽÊV>˜ViÀ]Ê vœÀÊiÝ>“«i]Ê>ÊVœ“«œÕ˜`ÊV>i`Ê £än™]ÊÜ ˆV Ê ˆÃÊ>ÊÃÞ˜Ì ïVÊ>˜>œ}ÕiʜvÊ£]Óx ]ÊÀi`ÕVi`ÊÌՓœÀÊ }ÀœÜÌ ÊLÞÊnäÊ«iÀVi˜Ì°Ê-ˆ“ˆ>ÀÊÀiÃՏÌÃÊ >ÛiÊLii˜Ê >ÌÌ>ˆ˜i`ʈ˜Ê>˜ˆ“>Ê“œ`iÃʜvÊLÀi>ÃÌÊ>˜`Ê«ÀœÃÌ>ÌiÊ V>˜ViÀ°Ê`i˜Ìˆvވ˜}ÊÌ iÊ}i˜iÃÊ>V̈Û>Ìi`ÊLÞÊÌ ˆÃÊ ÃÞ˜Ì ïVÊÛiÀȜ˜ÊœvÊ Ê >ÃÊ i«i`Êi݇ «>ˆ˜ÊÌ iÃiÊÀi뜘ÃiðÊ1˜Vœ˜ÌÀœi`Ê «ÀœˆviÀ>̈œ˜]ʜÀÊ}ÀœÜÌ ]ʈÃÊ>Ê >‡ “>ÀŽÊœvÊÌՓœÀÊViÃ]Ê>˜`Ê £än™Ê Ü>ÃÊà œÜ˜Ê̜ÊÃÕ««ÀiÃÃÊÌ iÊViÃ½Ê >LˆˆÌÞÊ̜ʓՏ̈«ÞÊLÞÊ>ÌiÀˆ˜}ÊÌ iÊ >V̈ۈÌÞÊ œvÊ >Ê ˜Õ“LiÀÊ œvÊ `ˆvviÀi˜ÌÊ }i˜iðÊ"˜iÊ}i˜iÊÀ>“«i`ÊÕ«ÊLÞÊÌ iÊVœ“«œÕ˜` p  {xAp ˆÃÊ ÜiÊ Ž˜œÜ˜Ê vœÀÊ ÌÀˆ}}iÀˆ˜}Ê }ÀœÜÌ Ê>ÀÀiÃÌʈ˜Ê˜œÀ“>ÊViÃÊÜ œÃiÊ ʈÃÊ `>“>}i`]ÊÌ iÀiLÞÊÀi`ÕVˆ˜}ÊÌ iˆÀÊÀˆÃŽÊvœÀÊLiVœ“‡ ˆ˜}ÊV>˜ViÀœÕðʘÊ>``ˆÌˆœ˜]Ê £än™Ê>V̈Û>ÌiÃÊ "*9,/ÊÓääÇÊ-  / Ê ,  ]Ê ° CERTAIN hFORTIlEDv PRODUCTS &OODS PROVIDE RELATIVELY SMALL DOSES OF $ COMPARED WITH AMOUNTS MADE BY THE SKIN IN RESPONSE TO 56" LIGHT )5  INTERNATIONAL UNITS #OD LIVER OIL  TBSP    )5 $ #OOKED TUNA SARDINES MACKEREL OR SALMON n OZ  n )5 $ 3HIITAKE MUSHROOMS FRESH  OZ   )5 $ DRIED  OZ    )5 $ %GG YOLK  )5 $ OR $ &ORTIlED DAIRY PRODUCTS ORANGE JUICE OR CEREALS ONE SERVING  n )5 $ OR $ &ULL BODY EXPOSURE TO 56"  TO  MINUTES AT MIDDAY IN SUMMER FAIR SKIN    )5 $ 3#)%.4)&)# !-%2)#!.  +* ;$ ). !#4)/.= ! "2/!$ !#4).' '%.% 37)4#( 4HE BIOLOGICALLY ACTIVE FORM OF VITAMIN $ ˆ $ ˆ TURNS hONv CERTAIN GENES LEADING TO THE MANUFACTURE OF THE PROTEINS THEY ENCODE 4HOSE PROTEINS MAY HAVE LOCAL OR WIDESPREAD PHYSIOLOGICAL EFFECTS -ORE THAN   DIFFERENT GENES IN AT LEAST A DOZEN TISSUES AND CELL TYPES THROUGHOUT THE BODY ARE THOUGHT TO BE REGULATED BY  $ #ELL NUCLEUS  )NSIDE A CELL NUCLEUS THE  $ MOLECULE BINDS TO A PROTEIN CALLED THE VITAMIN $ RECEPTOR 6$2 L  $ 6ITAMIN $ RESPONSE ELEMENT 6$2  4HE 6$2 THEN FORMS A COMPLEX WITH A SIMILAR PROTEIN THE L RETINOID X RECEPTOR 282 AND TOGETHER THE DUO BINDS TO A REGION IN THE $.! STRAND KNOWN AS A VITAMIN $ RESPONSE ELEMENT 4RANSCRIPTION FACTORS 282 'ENE  6$2 282 BINDING TO THE RESPONSE ELEMENT L RECRUITS TRANSCRIPTION FACTOR PROTEINS TO THE COMPLEX LEADING TO TRANSCRIPTION OF THE NEARBY GENE 'ENE TRANSCRIPT  4HE GENE TRANSCRIPT THEN LEAVES THE NUCLEUS TO BE TRANSLATED L BY CELLULAR MACHINERY IN THE CYTOPLASM INTO A lNISHED PROTEIN 4)335%3 !&&%#4%$ "9 6)4!-). $ 4HE 6$2 RECEPTOR PROTEIN  IS FOUND IN MANY BODY TISSUES AS WELL AS CIRCULATING IMMUNE CELLS INDICATING A ROLE FOR ACTIVE VITAMIN $ IN REGULATING GENE ACTIVITY IN THOSE LOCATIONS 4HE LIST BELOW INCLUDES SOME OF THE TISSUES AND CELLS WHERE  $ ACTION HAS BEEN ESTABLISHED "ONE "RAIN "REAST &AT )NTESTINE )MMUNE CELLS +IDNEYS ,IVER .ERVES 0ANCREAS 0ARATHYROID GLAND 0ROSTATE 3KIN KERATINOCYTES +- 3 # ) % . 4 ) & ) # ! - % 2 ) # ! . }i˜iÃÊÌ >ÌÊ`ˆÀiVÌÊÌՓœÀÊViÃÊ̜ÊLiVœ“iʓœÀiÊ`ˆv‡ viÀi˜Ìˆ>Ìi`]Ê>ʓ>ÌÕÀiÊÃÌ>ÌiÊÌ >Ìʏˆ“ˆÌÃÊ>ÊVi½ÃÊ >LˆˆÌÞÊ̜ʫÀœˆviÀ>Ìi°Ê ˜œÌ iÀÊ`œâi˜Ê}i˜iÃʈ˜ÛœÛi`ʈ˜Ê>ÊVi½ÃÊi˜‡ iÀ}Þʓ>˜>}i“i˜ÌÊ>˜`ÊÃiv‡`i̜݈wV>̈œ˜Ê >ÛiÊ >ÃœÊLii˜Êˆ˜Ži`ÊÌœÊ £än™½ÃÊ>˜ÌˆÌՓœÀÊ>V̈œ˜Ã°Ê / >ÌÊiÝ«iÀˆ“i˜Ì>ÊVœ“«œÕ˜`]ÊÜ ˆV ÊÜ>ÃÊV i“‡ ˆV>ÞÊ`iÈ}˜i`ÊÌœÊ >ÛiÊ£]Óx ‡ˆŽiÊ>V̈ۈÌÞÊÜˆÌ ‡ œÕÌÊV>ÕȘ}Ê̜݈VʏiÛiÃʜvÊV>VˆÕ“Ê̜ÊLՈ`ÊÕ«Ê ˆ˜ÊÌ iÊLœœ`ÃÌÀi>“Ê>˜`ÊLœ`ÞÊ̈ÃÃÕiÃ]ʈÃʜ˜iʜvÊ ÃiÛiÀ>Ê«œÌi˜Ìˆ>ÊV>˜ViÀÊÌ iÀ>«ˆiÃÊ`iÛiœ«i`ÊLÞÊ « >À“>ViṎV>ÊVœ“«>˜ˆiÃÊÌœÊ >À˜iÃÃÊۈÌ>“ˆ˜Ê ½ÃÊ«œÜiÀvՏÊ>˜ÌˆÌՓœÀÊ«Àœ«iÀ̈iÃ°Ê ˜`ii`]ʜÕÀʏ>LœÀ>̜ÀÞÊ}ÀœÕ«Ê>ÌÊVˆÊ1˜ˆ‡ ÛiÀÈÌÞÊÜ>ÃÊ>ÃœÊˆ˜ÛiÃ̈}>̈˜}Ê ½ÃÊV>˜ViÀ‡Ài>Ìi`Ê >V̈œ˜Ãʈ˜ÊÓää{ÊÜ i˜ÊÜiʈ˜>`ÛiÀÌi˜ÌÞÊ ˆÌʜ˜Ê>Ê Vœ“«iÌiÞÊ`ˆvviÀi˜ÌÊvœÀ“ÊœvÊ« ÞȜœ}ˆV>Ê`i‡ vi˜ÃiÊ}œÛiÀ˜i`ÊLÞÊ£]Óx °Ê>˜ÞʜvÊÌ iÊ}i˜iÃÊ Ài}Տ>Ìi`ÊLÞÊۈÌ>“ˆ˜Ê Ê >ÛiÊLii˜Ê`ˆÃVœÛiÀi`ʈ˜Ê ÀiVi˜ÌÊÞi>ÀÃÊLÞÊÃVˆi˜ÌˆÃÌÃÊÃV>˜˜ˆ˜}Ê«>ÀÌÃʜvÊÌ iÊ Õ“>˜Ê}i˜œ“i]ʏœœŽˆ˜}ÊvœÀÊۈÌ>“ˆ˜Ê ÊÀi뜘ÃiÊ ii“i˜ÌÃÊ­6 , î p Ì iÊ`ˆÃ̈˜V̈ÛiÊÃiµÕi˜ViÃÊ œvÊ ÊVœ`iÊÌ >ÌʏˆiÊ>`>Vi˜ÌÊ̜Ê}i˜iÃ]Ê̜ÊÜ ˆV Ê Ì iÊ6 ,‡,8,Ê«ÀœÌiˆ˜ÊVœ“«iÝÊLˆ˜`ðʘÊVœ‡ "*9,/ÊÓääÇÊ-  >LœÀ>̈œ˜ÊÜˆÌ Ê-ޏۈiÊ>`iÀʜvÊÌ iÊ1˜ˆÛiÀÈÌÞÊ œvÊœ˜ÌÀi>]ÊÜiÊÕÃi`Ê>ÊVœ“«ÕÌiÀÊ>}œÀˆÌ “Ê`i‡ È}˜i`Ê̜ÊÃV>˜ÊÌ iÊi˜ÌˆÀiÊ}i˜œ“i]ÊÃiiŽˆ˜}ʜÕÌÊ 6 , ÃÊ>˜`ʓ>««ˆ˜}ÊÌ iˆÀÊ«œÃˆÌˆœ˜ÃÊÀi>̈ÛiÊÌœÊ ˜i>ÀLÞÊ}i˜iÃ°Ê Ì œÕ} ÊÌ iÃiʓ>««ˆ˜}ÊÃÌÕ`ˆiÃÊ`ˆ`Ê i«ÊÕÃÊ ÌœÊLiÌÌiÀÊ՘`iÀÃÌ>˜`ÊܓiʜvÊÌ iÊ>˜ÌˆV>˜ViÀÊ>V‡ ̈œ˜ÃʜvÊۈÌ>“ˆ˜Ê ]ÊÌ iÞÊ>ÃœÊÀiÛi>i`Ê6 , ÃÊ Þˆ˜}ÊVœÃiÊ̜ÊÌܜÊ}i˜iÃÊÌ >ÌÊi˜Vœ`iÊ>˜Ìˆ“ˆVÀœ‡ Lˆ>Ê«i«Ìˆ`iÃÊV>i`ÊV>Ì iˆVˆ`ˆ˜Ê>˜`Ê`ivi˜Ãˆ˜Ê LiÌ>ÊÓ°Ê/ iÃiÊÓ>Ê«ÀœÌiˆ˜ÃÊ>VÌÊ>Ãʘ>ÌÕÀ>Ê>˜Ìˆ‡ LˆœÌˆVÃÊ>}>ˆ˜ÃÌÊ>Ê܈`iÊëiVÌÀՓʜvÊL>VÌiÀˆ>]Êۈ‡ ÀÕÃiÃÊ>˜`Êv՘}ˆ°Ê7iÊ«ÕÀÃÕi`ÊÌ ˆÃʏi>`ÊÜˆÌ ÊÃÌÕ`‡ ˆiÃʈ˜ÊVՏÌÕÀi`Ê Õ“>˜ÊViÃÊ>˜`ÊvœÕ˜`ÊÌ >ÌÊi݇ «œÃÕÀiÊ̜ʣ]Óx ÊV>ÕÃi`Ê>ÊÀi>̈ÛiÞʓœ`iÃÌÊ ˆ˜VÀi>Ãiʈ˜ÊÌ iÊViÃ½Ê“>˜Õv>VÌÕÀiʜvÊÌ iÊ`ivi˜‡ ȘÊLiÌ>ÊÓÊ«i«Ìˆ`i°Ê ÕÌʈ˜Ê>ʘՓLiÀʜvÊ`ˆvviÀi˜ÌÊ ViÊÌÞ«ià p ˆ˜VÕ`ˆ˜}ʈ““Õ˜iÊÃÞÃÌi“ÊViÃÊ>˜`Ê ŽiÀ>̈˜œVÞÌià p Ì iÊÀˆÃiʈ˜ÊV>Ì iˆVˆ`ˆ˜Ê«Àœ`ÕV‡ ̈œ˜ÊÜ>ÃÊ`À>“>̈V°Ê7iʘiÝÌÊ`i“œ˜ÃÌÀ>Ìi`ÊÌ >ÌÊ ˆ““Õ˜iÊ ViÃÊ ÌÀi>Ìi`Ê ÜˆÌ Ê £]Óx ]Ê Ü i˜Ê i݇ «œÃi`Ê̜ʫ>Ì œ}i˜ˆVÊL>VÌiÀˆ>]ÊÀii>Ãi`Êv>V̜Àà p «ÀiÃՓ>LÞÊV>Ì iˆVˆ`ˆ˜ p Ì >Ìʎˆi`ʜvvÊÌ iÊ L>VÌiÀˆ>° / Ê ,  ]Ê ° .OVEMBER   !.$2%7 37)&4 &INISHED PROTEIN  ,5#9 2%!$).' )++!.$!  !.! 0!,)*!.  * ˆˆ«ÊˆÕÊ>˜`Ê,œLiÀÌÊœ`ˆ˜ÊœvÊÌ iÊ1˜ˆÛiÀ‡ ÈÌÞʜvÊ >ˆvœÀ˜ˆ>]ÊœÃʘ}iiÃ]Ê>˜`ÊÌ iˆÀÊVœ‡ >LœÀ>̜ÀÃÊÃÕLÃÌ>˜Ìˆ>ÞÊ>`Û>˜Vi`ÊÌ ˆÃʏˆ˜iʜvʈ˜‡ ÛiÃ̈}>̈œ˜Ê>ÃÌÊÞi>ÀÊLÞÊà œÜˆ˜}ÊÌ >ÌÊ Õ“>˜Êˆ“‡ “Õ˜iÊViÃÊÀi뜘`Ê̜ÊL>VÌiÀˆ>ÊViÊÜ>ÃÊLÞÊ “>˜Õv>VÌÕÀˆ˜}ÊLœÌ Ê6 ,Ê«ÀœÌiˆ˜ÃÊ>˜`ÊÌ iÊi˜‡ âޓiÊÌ >ÌÊVœ˜ÛiÀÌÃÊVˆÀVՏ>̈˜}ÊÓx ʈ˜ÌœÊÌ iÊLˆ‡ œœ}ˆV>ÞÊ>V̈ÛiÊ£]Óx °Ê˜ÊÌ iÊ}ÀœÕ«½ÃÊiÝ«iÀˆ‡ “i˜ÌÃ]ÊÌ iÃiÊiÛi˜ÌÃʈ˜`ÕVi`ÊÌ iʈ““Õ˜iÊViÃÊÌœÊ ÃÌ>ÀÌÊ«Àœ`ÕVˆ˜}ÊV>Ì iˆVˆ`ˆ˜Ê>˜`Ê̜Ê`i“œ˜ÃÌÀ>ÌiÊ >˜Ìˆ“ˆVÀœLˆ>Ê>V̈ۈÌÞÊ>}>ˆ˜ÃÌÊ>ÊÛ>ÀˆiÌÞʜvÊL>V‡ ÌiÀˆ>]ʈ˜VÕ`ˆ˜}ʜ˜iÊÌ >ÌʈÃÊ«iÀ >«ÃÊÌ iʓœÃÌʈ˜‡ ÌÀˆ}Ո˜}\ÊÞVœL>VÌiÀˆÕ“ÊÌÕLiÀVՏœÃˆÃ°Ê/ ÕÃ]Ê vœÀÊÌ iÊwÀÃÌÊ̈“i]ÊÌ iÊ}ÀœÕ«ÊÀiÛi>i`Ê>Ê«>ÕÈLiÊ L>ÈÃÊvœÀÊÌ iʓÞÃÌiÀˆœÕÃÊivwV>VÞʜvÊÌ iÊÌÕLiÀVՇ œÃˆÃÊÃ՘à ˆ˜iÊVÕÀi\ÊÌ iÊÃ՘‡Ãœ>Ži`ÊVœ˜Û>iÇ Vi˜ÌýÊۈÌ>“ˆ˜Ê ÊLœœÃÌÊVœÕ`Ê >ÛiÊ«ÀœÛˆ`i`Ê Ì iˆÀʈ““Õ˜iÊViÃÊÜˆÌ ÊÌ iÊÀ>Üʓ>ÌiÀˆ>Ê˜ii`‡ i`Ê̜Ê}i˜iÀ>ÌiÊ>ʘ>ÌÕÀ>Ê>˜ÌˆLˆœÌˆVÊÌ >ÌÊvœÕ} ÌÊ œvvÊÌ iÊ/ ÊL>VÌiÀˆ>°Ê ÃÊ}>«Ãʈ˜ÊœÕÀÊ՘`iÀÃÌ>˜`ˆ˜}ʜvÊۈÌ>“ˆ˜Ê Ê « ÞȜœ}ÞÊ>ÀiÊwi`ʈ˜]ÊÀiÃi>ÀV iÀÃÊ >ÛiÊVœ“iÊ ÌœÊ>««ÀiVˆ>ÌiÊÌ >ÌÊ>ʘՓLiÀʜvÊ ½ÃÊ«ÀœÌiV̈ÛiÊ>V‡ ̈œ˜Ãʈ˜ÊÌ iÊLœ`Þʓˆ} ÌÊ >ÛiÊiۜÛi`ÊvÀœ“Êv՘V‡ ̈œ˜ÃʜÀˆ}ˆ˜>̈˜}Ê>ÌÊÌ iʓœiVՏi½ÃÊÜÕÀVi]ʈ˜ÊÌ iÊ ÃŽˆ˜°Ê/ iÊ}ÀœÜÌ ‡>ÀÀiÃ̈˜}ʈ˜yÕi˜ViʜvÊ£]Óx Ê œ˜ÊV>˜ViÀÊViÃʓ>ŽiÃÊÃi˜Ãiʈ˜ÊÌ ˆÃʏˆ} ÌÊLiV>ÕÃiÊ iÝViÃÃÊ16 ÊiÝ«œÃÕÀiʈÃʎ˜œÜ˜Ê̜Ê`>“>}iÊÌ iÊ ʜvÊΈ˜ÊViÃ]ÊÜ ˆV ÊV>˜Êi>`ÊÌ i“Ê̜ÊLi‡ Vœ“iÊV>˜ViÀœÕðÊ-œ“iÊ >ÛiÊ>ÃœÊëiVՏ>Ìi`Ê Ì >ÌÊÌ iÊ>˜Ìˆ“ˆVÀœLˆ>ÊÀi뜘ÃiÊÀi}Տ>Ìi`ÊLÞÊۈ‡ Ì>“ˆ˜Ê Ê ˆÃÊ >˜Ê >`>«Ì>̈œ˜Ê Ì >ÌÊ “ˆ} ÌÊ >ÛiÊ iۜÛi`Ê̜ÊVœ“«i˜Ã>ÌiÊvœÀÊ ½ÃÊÀœiʈ˜ÊÃÕ««ÀiÃÇ ˆ˜}ÊViÀÌ>ˆ˜ÊœÌ iÀʈ““Õ˜iÊÃÞÃÌi“ÊÀi>V̈œ˜Ã p ëiVˆwV>Þ]ÊÌ œÃiÊÌ >Ìʏi>`Ê̜ÊiÝViÃÈÛiʈ˜y>“‡ “>̈œ˜°ÊÃʓ>˜ÞʜvÊÕÃʎ˜œÜÊ̜œÊÜiÊvÀœ“ÊiÝ«i‡ Àˆi˜Vi]ÊiÝViÃÈÛiÊ16 ÊiÝ«œÃÕÀiÊV>ÕÃiÃÊÃ՘LÕÀ˜i`Ê ÃŽˆ˜]ÊÜ ˆV Ê>ÌÊÌ iÊ̈ÃÃÕiʏiÛiÊÀiÃՏÌÃʈ˜ÊyՈ`Ê LՈ`Õ«Ê>˜`ʈ˜y>““>̈œ˜°ÊÌ œÕ} Ê>ʏˆ“ˆÌi`Ê >“œÕ˜Ìʜvʈ˜y>““>̈œ˜ÊˆÃÊ>ÊLi˜iwVˆ>Ê“iV >‡ ˜ˆÃ“ÊvœÀÊܜ՘`Ê i>ˆ˜}Ê>˜`Ê i«ÃÊÌ iʈ““Õ˜iÊ ÃÞÃÌi“Êw} Ìʜvvʈ˜viV̈œ˜]Ê̜œÊ“ÕV ʈ˜y>““>‡ ̈œ˜ÊV>ÕÃiÃʈÌÃÊœÜ˜Ê >ۜV°Ê *iÀ >«ÃʘœÌÊÃÕÀ«ÀˆÃˆ˜}Þ]ÊÌ i˜]Ê>˜Êˆ“«ÀiÃÈÛiÊ Lœ`ÞʜvÊܜÀŽÊ˜œÜÊà œÜÃÊÌ >ÌÊ£]Óx Ê>ÃœÊ>VÌÃÊ >ÃÊ>˜Ê>˜Ìˆ‡ˆ˜y>““>̜ÀÞÊ>}i˜ÌÊÌ >ÌÊv՘V̈œ˜ÃÊLÞÊ ˆ˜yÕi˜Vˆ˜}ʈ““Õ˜iÊViÊˆ˜ÌiÀ>V̈œ˜Ã°ÊœÀÊiÝ>“‡ «i]Ê`ˆvviÀi˜ÌÊÃÕLÌÞ«iÃʜvʈ““Õ˜iÊViÃÊVœ““Õ‡ ˜ˆV>ÌiÊLÞÊÃiVÀï˜}Êv>V̜ÀÃÊV>i`ÊVÞ̜Žˆ˜iÃÊÌœÊ ˆ˜ˆÌˆ>ÌiÊ>Ê«>À̈VՏ>ÀÊÌÞ«iʜvʈ““Õ˜iÊÀi뜘Ãi°Ê 6ˆÌ>“ˆ˜Ê Ê >ÃÊLii˜Êà œÜ˜Ê̜ÊÀi«ÀiÃÃÊiÝ>}}iÀ‡ >Ìi`ʈ˜y>““>̜ÀÞÊÀi뜘ÃiÃÊLÞʈ˜ ˆLˆÌˆ˜}ÊÌ >ÌÊ VÞ̜Žˆ˜iÊVÀœÃÃÊÌ>Ž°Ê ˆÀiVÌÊiۈ`i˜ViʜvÊۈÌ>“ˆ˜Ê ½Ãʘ>ÌÕÀ>ÊÀœiʈ˜Ê «ÀiÛi˜Ìˆ˜}ʈ˜y>““>̈œ˜ÊV>“iÊwÀÃÌÊvÀœ“Ê>˜ˆ“>Ê W W W 3 C I ! M  C O M iÝ«iÀˆ“i˜ÌÃʈ˜ÊÌ iÊi>ÀÞÊ£™™äÃ]ÊÜ ˆV Êà œÜi`Ê Ì >ÌʓˆViÊÌÀi>Ìi`ÊÜˆÌ Ê£]Óx ÊÜiÀiÊ«ÀœÌiVÌi`Ê vÀœ“ÊÌ iʈ˜y>““>̈œ˜Ê˜œÀ“>ÞÊ>ÃÜVˆ>Ìi`ÊÜˆÌ Ê ÜœÕ˜`ÃÊ>˜`ÊÌ iÊV i“ˆV>ÊˆÀÀˆÌ>˜ÌÊ`ˆ˜ˆÌÀœLi˜‡ âi˜i]ÊÜ iÀi>ÃÊۈÌ>“ˆ˜Ê q`iwVˆi˜ÌʓˆViÊÜiÀiÊ Þ«iÀÃi˜ÃˆÌˆÛiÊ̜ÊÌ œÃiÊÃ>“iʈ˜ÃՏÌðÊ/ ˆÃʈ“‡ “Õ˜i‡ÃÕ««ÀiÃȘ}Êv՘V̈œ˜ÊœvÊۈÌ>“ˆ˜Ê ʈ““i‡ `ˆ>ÌiÞÊÃÕ}}iÃÌi`Ê>ÊÀ>˜}iʜvʘiÜÊÌ iÀ>«iṎVÊ «œÃÈLˆˆÌˆiÃÊvœÀÊÕȘ}ÊۈÌ>“ˆ˜Ê ʜÀʈÌÃÊ>˜>œ}ÕiÃÊ ˆ˜ÊÌ iÊVœ˜ÌÀœÊœvÊ>Õ̜ˆ““Õ˜iÊ`ˆÃi>ÃiÃÊÌ œÕ} ÌÊ ÌœÊLiÊV>ÕÃi`ÊLÞʜÛiÀ>V̈ÛiÊVÞ̜Žˆ˜iÊÀi뜘ÃiÃ]Ê ÃÕV Ê>ÃÊ>Õ̜ˆ““Õ˜iÊ`ˆ>LiÌiÃ]ʓՏ̈«iÊÃViÀœÃˆÃÊ ­-®Ê>˜`ʈ˜y>““>̜ÀÞÊLœÜiÊ`ˆÃi>Ãi° -ˆ˜ViÊÌ >ÌÊ̈“i]ÊÃVˆi˜ÌˆÃÌÃÊ >ÛiÊÀi>ˆâi`ÊÌ >ÌÊ “>˜ÞÊViÊÌÞ«iÃ]ʈ˜VÕ`ˆ˜}ʈ““Õ˜iÊViÃ]Ê>ÀiÊV>‡ «>LiʜvÊÕȘ}ÊVˆÀVՏ>̈˜}Ê£]Óx Ê>˜`ʜvÊVœ˜ÛiÀ̇ ˆ˜}ÊVˆÀVՏ>̈˜}ÊÓx Ê̜ÊÌ iÊ>V̈ÛiÊvœÀ“ÊœvÊÌ iÊۈ‡ Ì>“ˆ˜]ÊVœ˜wÀ“ˆ˜}ÊÌ >ÌÊÌ iÊ>˜Ìˆ‡ˆ˜y>““>̜ÀÞÊ >V̈œ˜ÃʜvÊ£]Óx Ê>ÀiʘœÌÊÀiÃÌÀˆVÌi`Ê̜ÊΈ˜ÊViÃÊ ˜œÀÊȓ«ÞÊ̜ÊÌ iÊVœ˜ÌiÝÌʜvÊÃ՘LÕÀ˜°Ê %PIDEMIC $EFICIENCY ,iVœ}˜ˆÌˆœ˜ÊÌ >ÌÊ£]Óx Ê >ÃÊ>ÊLÀœ>`ÊÀ>˜}iʜvÊ Lˆœœ}ˆV>Ê>V̈ۈ̈iÃÊv>ÀÊLiޜ˜`ʈÌÃÊÀœiʈ˜ÊV>Vˆ‡ Õ“Ê œ“iœÃÌ>ÈÃÊ >ÃÊÌ ÀœÜ˜Êˆ˜ÌœÊà >À«ÊÀiˆivÊ>Ê >À}iÊLœ`ÞʜvÊi«ˆ`i“ˆœœ}ˆV>Êiۈ`i˜ViÊÌ >ÌʏœÜÊ ÛˆÌ>“ˆ˜Ê ʏiÛiÃÊVœÀÀi>ÌiÊÃÌÀœ˜}ÞÊÜˆÌ ÊViÀÌ>ˆ˜Ê ÌÞ«iÃʜvÊ`ˆÃi>Ãi]Ê>“œ˜}ÊÌ i“ÊV>˜ViÀÃ]Ê>Õ̜ˆ“‡ “Õ˜iÊVœ˜`ˆÌˆœ˜ÃÊ>˜`ÊiÛi˜Êˆ˜viV̈œÕÃÊ`ˆÃi>ÃiÃ]Ê ÃÕV Ê>Ãʈ˜yÕi˜â>]Ê>ÃÊÜiÊ>ÃÊÜˆÌ ÊÃi>ܘ>ÊÛ>Àˆ‡ >̈œ˜Ãʈ˜Êˆ˜iÃÃÊÀ>ÌiðʘÊ>``ˆÌˆœ˜]ʓ>˜ÞʜvÊÌ iÊ ˜œÌi`Ê« ÞȜœ}ˆV>ÊÀi뜘ÃiÃÊ̜ÊۈÌ>“ˆ˜Ê ÊÃii˜Ê LœÌ ʈ˜ÊÌ iʏ>LœÀ>̜ÀÞÊ>˜`ʈ˜ÊVˆ˜ˆV>ÊÃÌÕ`ˆiÃÊ>ÀiÊ œ«Ìˆ“ˆâi`Ê œ˜ÞÊ Ü i˜Ê VˆÀVՏ>̈˜}Ê Vœ˜Vi˜ÌÀ>‡ ̈œ˜ÃʜvÊÓx Ê>ÀiÊ ˆ} iÀÊÌ >˜ÊˆÃÊÌÞ«ˆV>Êˆ˜Ê“>˜ÞÊ «œ«Õ>̈œ˜Ã°Êi“LiÀÃʜvÊÌ iÊۈÌ>“ˆ˜Ê ÊÀiÃi>ÀV Ê Vœ““Õ˜ˆÌÞÊ>ÀiÊÌ iÀivœÀiÊVœ“ˆ˜}Ê̜Ê>Ê܈`i‡ ëÀi>`ÊVœ˜Ãi˜ÃÕÃÊÌ >ÌÊÃÕLÃÌ>˜Ìˆ>Ê˜Õ“LiÀÃʜvÊ «iœ«iʈ˜ÊÌi“«iÀ>ÌiÊÀi}ˆœ˜ÃʜvÊÌ iÊܜÀ`Ê >ÛiÊ (/7 -5#( $ )3 $%3)2!",%  %STIMATES OF VITAMIN $ AVAILABLE TO THE BODY ARE BASED ON MEASUREMENTS OF $ CONCENTRATIONS IN BLOOD SERUM ,EVELS BETWEEN  AND  NANOGRAMS PER MILLILITER OF SERUM ARE CONSIDERED MINIMALLY SUFlCIENT FOR BONE HEALTH ALTHOUGH SOME BENElCIAL CELLULAR RESPONSES TO $ ARE OPTIMIZED AT HIGHER CONCENTRATIONS "ELOW  NGML HEALTH RISKS INCREASE ABOVE  NGML EXCESS CALCIUM BUILDUP IN BLOOD AND TISSUES AND SYMPTOMS OF TOXICITY ARE POSSIBLE "*9,/ÊÓääÇÊ-  / Ê ,  ]Ê ;4(% !54(/23= ,UZ % 4AVERA -ENDOZA AND *OHN ( 7HITE WORKED TOGETHER IN 7HITES LABORATORY AT -C'ILL 5NI VERSITY INVESTIGATING THE MOLECULAR ACTIVITIES OF VITAMIN $ IN HUMAN CELLS 4HEY HAVE UNCOVERED ASPECTS OF THE VITAMINS ROLE IN CANCER PRE VENTION AND DISCOVERED WITH THEIR COLLABORATORS THAT $ REGULATES CER TAIN GENES INVOLVED IN CELL RESPONS ES TO MICROBIAL INVADERS 4AVERA -ENDOZA IS NOW A POSTDOCTORAL FELLOW AT (ARVARD -EDICAL 3CHOOL STUDYING VITAMIN $ AND BREAST CAN CER (AVING WITNESSED VITAMIN $S HEALTH PROTECTING ACTIONS lRST HAND IN THE LAB BOTH AUTHORS TAKE SUPPLEMENTS DURING THE PARTS OF THE YEAR WHEN SUNLIGHT IS TOO WEAK IN THE NORTHERN CITIES WHERE THEY RESIDE TO PRODUCE ADEQUATE AMOUNTS IN SKIN 7HITE TAKES   INTERNATIONAL UNITS OF $ DAILY DURING THOSE hVITAMIN $ WIN TERv MONTHS AND 4AVERA -ENDOZA TAKES   !BOVE  NG 4OXICITY SYMPTOMS AND HYPERCALCEMIA  n NG 02%&%22%$ 2!.'%   n NG ).35&&)#)%.4 #ALCIUM ABSORPTION IMPAIRED  n NG $%&)#)%.4 2ICKETS SYMPTOMS MAY APPEAR #ANCER RISKS RISE !NTIMICROBIAL PEPTIDE RESPONSE MAY BE INHIBITED 3ERUM $ NGML ° 3#)%.4)&)# !-%2)#!.  +. ,% 3 # ) % . 4 ) & ) # ! - % 2 ) # ! . $ -!+%3 ! $)&&%2%.#% 'ROWING EVIDENCE SUGGESTS THAT CHRONICALLY LOW LEVELS OF VITAMIN $ RAISE A PERSONS RISK FOR CERTAIN MAJOR ILLNESSES %XAMPLES OF lND INGS BASED ON A POPULATIONS BLOOD SERUM $ LEVELS OR 56 EXPO SURE INCLUDE N  TO  HIGHER RISK FOR BREAST PROSTATE AND COLON CANCERS AT SERUM $ LEVELS BELOW  NGML N &IVE TIMES HIGHER RISK OF OVARIAN CANCER AMONG WOMEN LIVING AT HIGH LATITUDES FOR EXAMPLE .ORWAY AND )CELAND THAN WOMEN LIVING AT EQUATORIAL REGIONS N  LOWER RISK FOR ALL CANCERS AMONG .EBRASKA WOMEN AGE  AND OLDER TAKING   )5 OF $ DAILY OVER A THREE YEAR PERIOD COMPARED WITH A PLACEBO GROUP N  LOWER RISK FOR MULTIPLE SCLEROSIS AT SERUM $ LEVELS ABOVE  NGML THAN AT  NGML OR LESS N  LOWER LIFETIME RISK FOR AUTOIMMUNE TYPE  DIABETES IN &INNISH CHILDREN GIVEN   )5 OF $ DAILY DURING lRST YEAR OF LIFE )--5.% #%,, TREATED WITH  $ RESPONDS TO INFECTION BY TUBERCULOSIS BACTERIA  AND BY MAKING ANTIMICROBIAL CATHELICIDIN PEPTIDES   "*9,/ÊÓääÇÊ-  Ã̜Ài`ÊÃiÀՓÊÃ>“«iÃʜvÊܓiÊÃiÛi˜Ê“ˆˆœ˜Ê1°-°Ê À“ÞÊ>˜`Ê >ÛÞÊ«iÀܘ˜iÊ>ÃÊÜiÊ>ÃÊÌ iˆÀÊ i>Ì Ê ÀiVœÀ`ÃÊ̜ÊÃiiÊÜ ˆV ʈ˜`ˆÛˆ`Õ>ÃÊ >`Ê`iÛiœ«i`Ê -ÊLiÌÜii˜Ê£™™ÓÊ>˜`ÊÓää{°Ê/ iÊÀiÃi>ÀV iÀÃÊ vœÕ˜`Ê>ÊÈ}˜ˆwV>˜ÌÞʏœÜiÀÊÀˆÃŽÊœvʏ>ÌiÀÊ`iÛiœ«‡ ˆ˜}ÊÌ iÊ`ˆÃi>Ãiʈ˜ÊÌ iÊ}ÀœÕ«ÊÜˆÌ Ê ˆ} ÊÃiÀÕ“Ê Óx ʏiÛiÃÊ>ÌÊÌ iÊ̈“iÊÌ iÊÃ>“«iÊÜ>ÃÊÌ>Ži˜°Ê-œ‡ `ˆiÀÃÊÜˆÌ ÊÃiÀՓÊÓx ÊVœ˜Vi˜ÌÀ>̈œ˜ÃÊ>LœÛiÊ{äÊ ˜>˜œ}À>“ÃÊ«iÀʓˆˆˆÌiÀÊ >`Ê>ÊÈÓÊ«iÀVi˜ÌʏœÜiÀÊ ÀˆÃŽÊÌ >˜ÊÌ iÊ܏`ˆiÀÃÊÜ œÃiÊVœ˜Vi˜ÌÀ>̈œ˜ÃÊ ÜiÀiÊÓxʘ}ɓÊœÀÊLiœÜ°Ê i>ÃÕÀˆ˜}ÊVˆÀVՏ>̈˜}ʏiÛiÃʜvÊÓx ʈÃÊÌ iÊÕÃՇ >Ê“iÌ œ`ʜvÊ}>Õ}ˆ˜}ÊۈÌ>“ˆ˜Ê Ê>Û>ˆ>LˆˆÌÞʈ˜Ê Ì iÊLœ`Þ°Êi˜iÀ>ÞÊ>}Àii`ʜ˜Ê i>Ì ÊÃÌ>˜`>À`Ã]Ê L>Ãi`ʏ>À}iÞʜ˜ÊLœ˜i‡vœÀ“ˆ˜}ʘii`Ã]Ê œ`ÊVˆÀVՇ >̈˜}ÊÓx ʏiÛiÃʜvÊÎäÊ̜Ê{xʘ}ɓÊ̜ÊLiʓˆ˜ˆ‡ “>ÞÊÃÕvwVˆi˜Ì°Ê-iÀՓÊۈÌ>“ˆ˜Ê ÊVœ˜Vi˜ÌÀ>‡ ̈œ˜ÃÊLiœÜÊLiÌÜii˜ÊÓ£Ê>˜`Êәʘ}ɓÊ>ÀiÊVœ˜Ãˆ`‡ iÀi`Ê ˆ˜ÃÕvvˆVˆi˜ÌÊ >˜`Ê œvÌi˜Ê >VVœ“«>˜ˆi`Ê LÞÊ `iVÀi>Ãi`ÊLœ˜iÊ`i˜ÃˆÌÞ°Ê-œ“iÊÃޓ«Ìœ“ÃʜvÊÀˆVŽ‡ iÌÃʓ>ÞÊ>««i>ÀÊÜ i˜ÊVœ˜Vi˜ÌÀ>̈œ˜ÃÊv>ÊLiœÜÊ Óäʘ}ɓ]Ê>˜`ÊÌ iÊÀˆÃŽÊœvÊVœœ˜ÊV>˜ViÀÊÀˆÃið -ÕV ʏœÜÊVœ˜Vi˜ÌÀ>̈œ˜ÃÊ>ÀiÊ՘vœÀÌ՘>ÌiÞÊ >Ê̜œÊVœ““œ˜]ÊiëiVˆ>Þʈ˜Ê܈˜ÌiÀ°Ê˜ÊiLÀՇ >ÀÞÊ>˜`Ê>ÀV ʜvÊÓääx]ÊvœÀÊiÝ>“«i]Ê>ÊÃÕÀÛiÞʜvÊ {ÓäÊ i>Ì ÞÊvi“>iÃÊ>VÀœÃÃʘœÀÌ iÀ˜Ê ÕÀœ«i p ˆ˜Ê i˜“>ÀŽÊ­ œ«i˜ >}i˜\Êxxcʏ>̈ÌÕ`i®]ʈ˜>˜`Ê ­iÃˆ˜Žˆ\ÊÈäc®]ÊÀi>˜`Ê­ œÀŽ\ÊxÓc®Ê>˜`Ê*œ>˜`Ê ­7>ÀÃ>Ü\ÊxÓc® p vœÕ˜`ÊÌ >ÌʙÓÊ«iÀVi˜ÌʜvÊ>`œ‡ iÃVi˜ÌÊ}ˆÀÃʈ˜ÊÌ iÃiÊVœÕ˜ÌÀˆiÃÊ >`ÊÓx ʏiÛiÃÊ iÃÃÊÌ >˜ÊÓäʘ}ɓÊ>˜`ÊÌ >ÌÊÎÇÊ«iÀVi˜ÌʜvÊÌ iÊ }ˆÀÃÊÜiÀiÊÃiÛiÀiÞÊ`iwVˆi˜Ì]ÊÜˆÌ ÊÓx ʏiÛiÃʜvÊ iÃÃÊÌ >˜Ê£äʘ}ɓ°Ê“œ˜}ÊÌ iʜ`iÀÊܜ“i˜Ê ÌiÃÌi`]ÊÎÇÊ«iÀVi˜ÌÊÜiÀiÊvœÕ˜`Ê̜ÊLiÊۈÌ>“ˆ˜Ê Ê `iwVˆi˜ÌÊ>˜`Ê£ÇÊ«iÀVi˜ÌÊÜiÀiÊÃiÛiÀiÞÊ`iwVˆi˜Ì° iޜ˜`ʏ>̈ÌÕ`i]ÊÃiÛiÀ>Êv>V̜ÀÃÊV>˜ÊVœ˜ÌÀˆL‡ ÕÌiÊ̜ÊۈÌ>“ˆ˜Ê Ê`iwVˆi˜VÞ]Ê>˜`Ê«Àˆ“>ÀÞÊ>“œ˜}Ê Ì iÃiʈÃÊÀ>Vi°Ê7 ˆÌiÊΈ˜ÊÃÞ˜Ì iÈâiÃÊۈÌ>“ˆ˜Ê Ê ÃˆÝÊ̈“iÃÊv>ÃÌiÀÊÌ >˜Ê`>ÀŽÊΈ˜ÊLiV>ÕÃiÊ ˆ} iÀÊ iÛiÃʜvʓi>˜ˆ˜Êˆ˜Ê`>ÀŽiÀÊΈ˜ÊLœVŽÊ16Ê«i˜i‡ ÌÀ>̈œ˜ÊQÃiiʺ-Žˆ˜Ê ii«]»ÊLÞÊ ˆ˜>Ê°Ê>Lœ˜ÃŽˆÊ >˜`ÊiœÀ}iÊ >«ˆ˜ÆÊ3CIENTIlC !MERICAN "V̜LiÀÊÓääÓR°ÊÃÊ>ÊÀiÃՏÌ]ÊvÀˆV>˜‡“iÀˆV>˜ÃÊ }i˜iÀ>ÞÊ >ÛiʏiÛiÃʜvÊÓx ÊÌ >ÌÊ>ÀiÊ>««ÀœÝˆ‡ “>ÌiÞÊ >vÊÌ œÃiʜvÊÜ ˆÌiÃʈ˜ÊÌ iÊ1°-°Ê˜Êv>VÌ]Ê `>Ì>Ê}>Ì iÀi`ÊvœÀÊÌ iÊ1°-°Ê >̈œ˜>Êi>Ì Ê>˜`Ê ÕÌÀˆÌˆœ˜Ê Ý>“ˆ˜>̈œ˜Ê-ÕÀÛiÞÊà œÜi`ÊÌ >ÌÊ{ÓÊ «iÀVi˜ÌʜvÊvÀˆV>˜‡“iÀˆV>˜Êܜ“i˜ÊÌiÃÌi`ÊÜiÀiÊ ÃiÀˆœÕÏÞÊÓx Ê`iwVˆi˜Ì]ÊÜˆÌ ÊÃiÀՓÊVœ˜Vi˜ÌÀ>‡ ̈œ˜ÃʜvʏiÃÃÊÌ >˜Ê£xʘ}ɓ°Ê ˜VÀi>Ãi`Ê«ÕLˆVÊ>Ü>Ài˜iÃÃÊÌ >ÌÊiÝViÃÈÛiÊi݇ «œÃÕÀiÊ̜ÊÃ՘ˆ} ÌÊV>ÕÃiÃÊΈ˜Ê`>“>}iʈÃÊ՘‡ `œÕLÌi`ÞÊVœ˜ÌÀˆLṎ˜}Ê̜ÊۈÌ>“ˆ˜Ê Ê`iwVˆi˜VÞÊ >ÃÊÜi°Ê7 i˜Ê«Àœ«iÀÞÊ>««ˆi`]Ê̜«ˆV>ÊÃ՘‡ ÃVÀii˜ÃÊÀi`ÕViÊۈÌ>“ˆ˜Ê Ê«Àœ`ÕVi`ʈ˜ÊÌ iÊΈ˜Ê / Ê ,  ]Ê ° .OVEMBER   0(),)0 ,)5 -!2)! 4%2%3! /#(/! !.$ 2/"%24 -/$,). iÛiÃʜvÊۈÌ>“ˆ˜Ê ÊÌ >ÌÊ>ÀiÊÜiÊLiœÜʜ«Ìˆ“>Ê Vœ˜Vi˜ÌÀ>̈œ˜ÃÊvœÀÊ i>Ì ]Ê«>À̈VՏ>ÀÞÊ`ÕÀˆ˜}Ê Üˆ˜ÌiÀʓœ˜Ì Ã°Ê 16 ʏˆ} ÌÊ«i˜iÌÀ>ÌiÃÊÌ iÊ>̓œÃ« iÀiʓœÀiÊ `ˆÀiV̏Þʈ˜ÊÌ iÊÌÀœ«ˆVÃÊÌ >˜Êˆ˜Ê“œÀiÊÌi“«iÀ>ÌiÊ Ài}ˆœ˜ÃʜvÊÌ iÊ«>˜iÌ]ÊÜ ˆV ÊÀiViˆÛiÊÃÕLÃÌ>˜Ìˆ>Ê >“œÕ˜ÌÃʜvʈÌʜ˜ÞÊ`ÕÀˆ˜}ÊÌ iÊÃՓ“iÀ°Ê iV>ÕÃiÊ “œÃÌÊ«iœ«iʜLÌ>ˆ˜ÊۈÌ>“ˆ˜Ê ʓ>ˆ˜ÞÊÌ ÀœÕ} Ê 16 ÊiÝ«œÃÕÀi]ÊVˆÀVՏ>̈˜}ÊÓx ʏiÛiÃʈ˜Ê«œ«Õ‡ >̈œ˜ÃÊ}i˜iÀ>ÞÊ`ˆ“ˆ˜ˆÃ ÊÜˆÌ Êˆ˜VÀi>Ș}ʏ>̈‡ ÌÕ`i]Ê>Ì œÕ} ÊÛ>Àˆ>̈œ˜ÃÊ>ÌÊ>Ê}ˆÛi˜Ê>̈ÌÕ`iÊ`œÊ >ÀˆÃiÊLiV>ÕÃiʜvÊ`ˆvviÀˆ˜}ÊiÌ ˜ˆVˆÌˆiÃÊ>˜`Ê`ˆiÌÃ]Ê >ÃÊÜiÊ>ÃÊÛ>Àˆ>̈œ˜Ãʈ˜ÊœV>ÊVˆ“>ÌiÊ>˜`ÊiiÛ>‡ ̈œ˜°Ê œ˜ÃˆÃÌi˜ÌÊÜˆÌ ÊۈÌ>“ˆ˜Ê ½ÃʜLÃiÀÛi`Ê}i˜i‡ Ài}Տ>̜ÀÞÊ>V̈ۈ̈iÃ]Ê>ÊVi>ÀÊ>ÃÜVˆ>̈œ˜ÊˆÃÊÃii˜Ê LiÌÜii˜Êˆ˜VÀi>Ș}ʏ>̈ÌÕ`iÊ>˜`ʈ˜VÀi>Ãi`ÊÀˆÃŽÊ œvÊÃiÛiÀ>Êˆ˜iÃÃiÃ]ʓœÃÌÊVœ˜Ã«ˆV՜ÕÏÞÊ>Õ̜ˆ“‡ “Õ˜iÊ`ˆÃi>ÃiÃÊÃÕV Ê>ÃÊ-°Ê ÊV Àœ˜ˆVÊ«Àœ}ÀiÃÈÛiʈ˜iÃÃ]Ê-ʈÃÊV>ÕÃi`Ê LÞʈ““Õ˜iÊViÊ>ÃÃ>ՏÌÃʜ˜ÊÌ iÊ«ÀœÌiV̈Ûiʓއ iˆ˜Êà i>Ì ÊÌ >ÌÊÃÕÀÀœÕ˜`ÃʘiÀÛiÊwLiÀÃʜvÊÌ iÊ Vi˜ÌÀ>Ê˜iÀۜÕÃÊÃÞÃÌi“°ÊÌÃʈ˜Vˆ`i˜ViʈÃÊÈ}˜ˆw‡ V>˜ÌÞÊ ˆ} iÀʈ˜Ê>Ài>ÃÊv>ÀÌ iÃÌÊvÀœ“ÊÌ iÊiµÕ>̜ÀÊ ˆ˜Ê œÀÌ Ê“iÀˆV>]Ê ÕÀœ«iÊ>˜`ÊÕÃÌÀ>ˆ>]Ê>˜`Ê Vœ˜Ûˆ˜Vˆ˜}Êiۈ`i˜ViÊÃÕ}}iÃÌÃÊÌ >ÌÊÌ ˆÃÊ«>ÌÌiÀ˜Ê ÀiÃՏÌÃÊvÀœ“Ê`iVÀi>Ãi`Ê16 ÊiÝ«œÃÕÀi°Ê ˆÃi>ÃiÊ «Àœ}ÀiÃȜ˜Ê>˜`ÊÃޓ«Ìœ“Êy>Ài‡Õ«Ãʈ˜Ê-ÊÃÕv‡ viÀiÀÃÊ>ÃœÊ`ˆÃ«>ÞÊÜi‡iÃÌ>LˆÃ i`ÊÃi>ܘ>Ê Û>Àˆ>̈œ˜Ã]ÊÜˆÌ ÊÌ iÊ ˆ} iÃÌÊ`ˆÃi>ÃiÊ>V̈ۈÌÞʈ˜Ê Ì iÊëÀˆ˜}Ê­Ü i˜ÊVˆÀVՏ>̈˜}ÊÓx ʏiÛiÃÊܜՏ`Ê LiʏœÜiÃÌÊvœœÜˆ˜}ÊÌ iÊ܈˜ÌiÀ®Ê>˜`ÊÌ iʏi>ÃÌÊ`ˆÃ‡ i>ÃiÊ>V̈ۈÌÞʈ˜ÊÌ iÊv>]Ê>vÌiÀÊÌ iÊÃՓ“iÀ̈“iÊ LœœÃÌʜvÊ Î°ÊœÀÊiÝ>“«i]ÊÃVˆi˜ÌˆÃÌÃÊ>ÌÊÌ iÊ1˜ˆ‡ ÛiÀÈÌÞʜvÊ-œÕÌ iÀ˜Ê >ˆvœÀ˜ˆ>ÊvœÕ˜`Ê>˜Êˆ˜ÛiÀÃiÊ Ài>̈œ˜Ê>“œ˜}ÊǙʫ>ˆÀÃʜvʈ`i˜ÌˆV>ÊÌ܈˜ÃÊLi‡ ÌÜii˜Êˆ˜VÀi>Ãi`ÊÃ՘ÊiÝ«œÃÕÀiÊ`ÕÀˆ˜}ÊV ˆ` œœ`Ê >˜`Ê>ʏˆvï“iÊÀˆÃŽÊœvÊ`iÛiœ«ˆ˜}Ê-°Ê/ iÊÌ܈˜ÃÊ Ü œÊëi˜ÌʓœÀiÊ̈“iʜÕÌ`œœÀÃÊ>ÃÊV ˆ`Ài˜Ê >`Ê >ÃʓÕV Ê>ÃÊxÇÊ«iÀVi˜ÌʏœÜiÀÊÀˆÃŽÊœvÊ`iÛiœ«ˆ˜}Ê Ì iÊVœ˜`ˆÌˆœ˜° -ˆ“ˆ>ÀÊ«>ÌÌiÀ˜ÃʜvÊÀˆÃŽÊvœÀʈ˜iÃÃÊ >ÛiÊLii˜Ê `œVՓi˜Ìi`ÊvœÀÊ>Õ̜ˆ““Õ˜iÊ`ˆ>LiÌiÃÊ>˜`ÊvœÀÊ Àœ ˜½ÃÊ`ˆÃi>Ãi]Ê>˜Êˆ˜y>““>̜ÀÞÊ>Õ̜ˆ““Õ˜iÊ ˆ˜ÌiÃ̈˜>ÊVœ˜`ˆÌˆœ˜]Ê>ÃÊÜiÊ>ÃÊvœÀÊViÀÌ>ˆ˜ÊÌÞ«iÃÊ œvʓ>ˆ}˜>˜VÞ°Ê*œ«Õ>̈œ˜ÊÀ>ÌiÃʜvÊV>˜ViÀÃʜvÊ Ì iÊL>``iÀ]ÊLÀi>ÃÌ]ÊVœœ˜]ʜÛ>ÀÞÊ>˜`ÊÀiVÌՓʈ˜‡ VÀi>ÃiÊÌܜvœ`ÊvÀœ“ÊÜÕÌ Ê̜ʘœÀÌ Êˆ˜ÊÌ iÊ1°-°]Ê vœÀʈ˜ÃÌ>˜Vi°Ê ˜Ê>``ˆÌˆœ˜Ê̜ÊÌ iʓ>˜ÞÊÃÌÕ`ˆiÃÊVœÀÀi>̈˜}Ê Ã՘ÊiÝ«œÃÕÀiÊÜˆÌ Ê`ˆÃi>Ãiʈ˜Vˆ`i˜Vi]ÊÀiVi˜Ìʈ˜‡ ÛiÃ̈}>̈œ˜ÃÊ >Ûiʓ>`iÊȓˆ>ÀÊVœ˜˜iV̈œ˜ÃÊLi‡ ÌÜii˜Ê`ˆÃi>ÃiÊÀˆÃŽÊ>˜`Ê`ˆÀiVÌʓi>ÃÕÀi“i˜ÌÃʜvÊ VˆÀVՏ>̈˜}ÊÓx ÊVœ˜Vi˜ÌÀ>̈œ˜Ãʈ˜ÊLœœ`ÊÃiÀՓ°Ê ˜Êi˜œÀ“œÕÃÊÃÕÀÛiÞÊLÞÊÀiÃi>ÀV iÀÃÊ>ÌÊÌ iÊ>À‡ Û>À`Ê -V œœÊ œvÊ *ÕLˆVÊ i>Ì Ê œœŽi`Ê >ÌÊ Ì iÊ ;',/"!, 02/",%-= 6)4!-). $ 7).4%2 %XPOSURE TO 56" RADIATION IN SUNLIGHT IS THE SINGLE GREATEST SOURCE OF VITAMIN $ FOR MOST INDIVIDUALS SO LOCATION AND SEASON AFFECT A POPULA TIONS RISK OF DElCIENCY &OR PERIODS OF THE YEAR KNOWN AS VITAMIN $ WINTER 56" INTENSITY IS TOO WEAK AT SOME LATITUDES EVEN TO INDUCE VI TAMIN $ SYNTHESIS IN THE SKIN "ECAUSE OZONE BLOCKS 56" RAYS THE RAYS ARE MOST INTENSE NEAREST THE EQUATOR WHERE SUNLIGHT TRAVELS THE LEAST DISTANCE THROUGH THE EARTHS ATMOSPHERE AND VITAMIN $ SYNTHESIS IS POSSIBLE YEAR ROUND !N INCREASING ANGLE OF PENETRATION AT HIGHER LATI TUDES WEAKENS 56" INTENSITY UNTIL IT IS INSUFlCIENT ESPECIALLY DURING WINTER FOR MAKING VITAMIN $                            ± -/2% 4/ %80,/2% 5NRAVELING THE %NIGMA OF 6ITAMIN $ "EYOND $ISCOVERY 3ERIES .ATION AL !CADEMY OF 3CIENCES  WWWBEYONDDISCOVERYORGCON TENTVIEWARTICLEASPA   $IHYDROXYVITAMIN $ )S A $I RECT )NDUCER OF !NTIMICROBIAL 0EP TIDE 'ENE %XPRESSION 4IAN 4IAN 7ANG ET AL IN 6OL  PAGES n  4HE 0LEIOTROPIC !CTIONS OF 6ITAMIN $ 2OBERTO ,IN AND *OHN ( 7HITE IN 6OL  .O  PAGES n  *ANUARY  4HE 5RGENT .EED TO 2ECOMMEND AN )NTAKE OF 6ITAMIN $ 4HAT )S %FFECTIVE 2EINHOLD 6IETH ET AL IN 6OL  .O  PAGES n -ARCH  6ITAMIN $ $ElCIENCY -ICHAEL & (OLICK IN 6OL  .O  PAGES n *ULY   ,' 3 # ) % . 4 ) & ) # ! - % 2 ) # ! . LÞʓœÀiÊÌ >˜Ê™nÊ«iÀVi˜Ì°Ê ˜œÕ} ÊۈÌ>“ˆ˜Ê ÊvœÀÊ }œœ`Ê i>Ì ÊV>˜ÊLiÊÃÞ˜Ì iÈâi`ʈ˜ÊΈ˜ÊÜˆÌ ÊÃÕ˜Ê iÝ«œÃÕÀiÊÌ >Ìʓˆ} ÌÊ«Àœ`ÕViÊ>ÌʓœÃÌÊ>Êψ} ÌÊ «ˆ˜Ž˜iÃÃ]Ê œÜiÛiÀ°ÊœÀʓœÃÌÊv>ˆÀ‡Ê>˜`ʓi`ˆÕ“‡ Έ˜˜i`Ê«iœ«iʈ˜Ê œÀÌ Ê“iÀˆV>]ÊÌ ˆÃÊÌ>ŽiÃÊwÛiÊ ÌœÊ£xʓˆ˜ÕÌiÃʜvÊÃ՘ˆ} ÌÊLiÌÜii˜Ê£ä\ääÊ°°Ê >˜`ÊÎ\ääÊ*°°Ê`ÕÀˆ˜}ÊÌ iÊÃՓ“iÀ̈“i° 6ˆÌ>“ˆ˜Ê ÊÃÕ««i“i˜ÌÃÊVœÕ`Ê>``ÀiÃÃÊÌ iÊ ˆ} Ê«ÀiÛ>i˜ViʜvÊۈÌ>“ˆ˜Ê Ê`iwVˆi˜VÞʈ˜ÊÌi“‡ «iÀ>ÌiÊ✘iÃ]ÊLÕÌÊ œÜʓÕV Ê«iœ«iÊà œÕ`ÊÌ>ŽiÊ ˆÃÊÃ̈Ê>ÊÃÕLiVÌʜvÊ`iL>Ìi°Ê/ iÊ“iÀˆV>˜ÊV>`‡ i“ÞʜvÊ*i`ˆ>ÌÀˆVÃÊÀiVœ““i˜`ÃÊ>ʓˆ˜ˆ“Õ“Ê`>ˆ‡ Þʈ˜Ì>ŽiÊ­, ®ÊœvÊÓääʈ˜ÌiÀ˜>̈œ˜>Ê՘ˆÌÃÊ­1®Ê vœÀÊV ˆ`Ài˜]ÊÜ ˆV ʓ>˜ÞÊÀiÃi>ÀV iÀÃÊ >ÛiÊ>À‡ }Õi`ʈÃÊÃÕLœ«Ìˆ“>]ÊiÛi˜ÊvœÀÊÀˆVŽiÌÃÊ«ÀiÛi˜Ìˆœ˜°Ê / iÊ, ÊvœÀÊ>`ՏÌÃʈ˜Ê œÀÌ Ê“iÀˆV>Ê>˜`Ê Õ‡ Àœ«iÊVÕÀÀi˜ÌÞÊÀ>˜}iÃÊLiÌÜii˜ÊÓääÊ1Ê>˜`ÊÈääÊ 1]Ê`i«i˜`ˆ˜}ʜ˜Ê>}i°ÊvÌiÀÊÀiۈi܈˜}ʓՏ̈«iÊ ÃÌÕ`ˆiÃÊVœ“«>Àˆ˜}ÊۈÌ>“ˆ˜Ê ʈ˜Ì>ŽiÊ>˜`ÊÌ iÊÃi‡ ÀՓÊVœ˜Vi˜ÌÀ>̈œ˜ÃʜvÊÓx Ê«Àœ`ÕVi`]Ê>ÀÛ>À`Ê -V œœÊœvÊ*ÕLˆVÊi>Ì ÊÀiÃi>ÀV iÀÃÊ>˜`ÊœÌ iÀÃÊ Vœ˜VÕ`i`ʏ>ÃÌÊÞi>ÀÊÌ >ÌÊÌ iÊVÕÀÀi˜ÌÊ, ÃÊ>Àiʈ˜‡ >`iµÕ>Ìi°Ê/ iÞÊÃÕ}}iÃÌi`ÊÌ >ÌʘœÊiÃÃÊÌ >˜Ê >vÊ œvÊ1°-°Ê>`ՏÌÃʘii`i`Ê̜ÊVœ˜ÃՓiÊ>Ìʏi>ÃÌÊ£]äääÊ 1ʜvÊۈÌ>“ˆ˜Ê ÎÊ`>ˆÞÊ̜ÊÀ>ˆÃiÊÌ iˆÀÊÃiÀՓÊÓx Ê Vœ˜Vi˜ÌÀ>̈œ˜ÃÊ̜ÊÌ iʓˆ˜ˆ“Õ“Ê i>Ì ÞʏiÛiÊœvÊ Îäʘ}ɓ°Ê œÊÀՏiʜvÊÌ Õ“LÊi݈ÃÌÃÊvœÀÊV>VՏ>̇ ˆ˜}ÊÌ iÊÃiÀՓÊÓx ʏiÛiÃÊ}i˜iÀ>Ìi`ÊLÞÊÃÕ««i‡ “i˜ÌÃ]ÊLiV>ÕÃiʈ˜`ˆÛˆ`Õ>ÊÀi뜘ÃiÃÊV>˜ÊÛ>ÀÞÊ >˜`ʓ>ÞÊ`i«i˜`ʈ˜Ê«>ÀÌʜ˜ÊÌ iÊiÝÌi˜ÌʜvÊ`iw‡ Vˆi˜VÞ°ÊÊÃÌÕ`ÞʜvÊ«Ài}˜>˜ÌÊܜ“i˜Êà œÜi`]ÊvœÀÊ iÝ>“«i]ÊÌ >ÌÊ`>ˆÞÊ`œÃiÃʜvÊÈ]{ääÊ1ÊÀ>ˆÃi`ÊÃi‡ "*9,/ÊÓääÇÊ-  ÀՓÊÓx ʏiÛiÃÊ`À>“>̈V>ÞÊ՘̈ÊÌ iÞÊÀi>V i`Ê >LœÕÌÊ{äʘ}ɓÊ>˜`ÊÌ i˜ÊiÛii`ʜvv°Ê6ˆÌ>“ˆ˜Ê ÓÊ >ÃÊ>ÃœÊLii˜ÊvœÕ˜`Ê̜ÊLiʏiÃÃÊivviV̈ÛiÊÌ >˜Ê ÎÊ >ÌÊÀ>ˆÃˆ˜}Ê>˜`ÊÃÕÃÌ>ˆ˜ˆ˜}ÊÃiÀՓÊÓx ÊVœ˜Vi˜ÌÀ>‡ ̈œ˜ÃʜÛiÀÊ̈“i°Ê /œÝˆVÊۈÌ>“ˆ˜Ê ʜÛiÀ`œÃiÊÌ ÀœÕ} ÊÃÕ««i‡ “i˜Ì>̈œ˜ÊˆÃÊViÀÌ>ˆ˜ÞÊ«œÃÈLi]Ê>Ì œÕ} ʈÌʈÃÊ }i˜iÀ>ÞÊÃii˜ÊÜ i˜Ê`œÃiÃʜvÊ{ä]äääÊ1ʜÀʓœÀiÊ œvÊ Ê >ÛiÊLii˜ÊÌ>Ži˜Ê`>ˆÞÊvœÀÊ>˜ÊiÝÌi˜`i`Ê«i‡ Àˆœ`°Ê-՘à ˆ˜i‡ˆ˜`ÕVi`ÊۈÌ>“ˆ˜Ê Ê̜݈VˆÌÞÊ >ÃÊ ˜iÛiÀÊLii˜ÊœLÃiÀÛi`]Ê œÜiÛiÀ°Ê/œÊ«ÕÌÊÌ ˆÃʈ˜Ê «iÀëiV̈Ûi]Ê>˜Ê>`ՏÌÊܜ“>˜ÊÜˆÌ ÊÜ ˆÌiÊΈ˜Ê iÝ«œÃi`Ê̜ÊÃՓ“iÀÊÃ՘ÊÜ ˆiÊÜi>Àˆ˜}Ê>ÊLˆŽˆ˜ˆÊ }i˜iÀ>ÌiÃÊ>LœÕÌÊ£ä]äääÊ1ʜvÊۈÌ>“ˆ˜Ê ʈ˜Ê£xÊ ÌœÊÓäʓˆ˜ÕÌiðÊœ˜}iÀÊiÝ«œÃÕÀiÃÊ`œÊ˜œÌÊ}i˜iÀ‡ >ÌiÊ ˆ} iÀÊ>“œÕ˜ÌÃʜvÊۈÌ>“ˆ˜Ê ]ÊLiV>ÕÃiÊ16 Ê ˆ} ÌÊ>ÃœÊ`i}À>`iÃÊÌ iÊۈÌ>“ˆ˜]Ê«ÀiÛi˜Ìˆ˜}Ê̜œÊ “ÕV ʜvʈÌÊvÀœ“ÊLՈ`ˆ˜}Êիʈ˜ÊÌ iÊΈ˜°Ê VVՓՏ>̈˜}Êiۈ`i˜ViÊÃÕ}}iÃÌÃÊÌ >ÌÊÌ iÊÃÕL‡ ̏iÊ>˜`ʏœ˜}iÀ‡ÌiÀ“ÊivviVÌÃʜvÊiÛi˜Êψ} ÌÊۈÌ>“ˆ˜Ê Ê`iwVˆi˜VÞʓ>ÞÊLiʓՏ̈vœ`Ê>˜`ʓ>˜ˆviÃÌi`Ê >ÌiÀʈ˜Êˆvi]ʈ˜ÊÌ iÊvœÀ“Êœvʈ˜VÀi>Ãi`ÊvÀiµÕi˜VÞÊ œvÊLœ˜iÊvÀ>VÌÕÀiÃÊ>˜`Êi˜ >˜Vi`ÊÃÕÃVi«ÌˆLˆˆÌÞÊÌœÊ ˆ˜viV̈œ˜Ê>˜`Ê>Õ̜ˆ““Õ˜iÊ`ˆÃi>ÃiÃ]Ê>ÃÊÜiÊ>ÃÊ iiÛ>Ìi`ÊvÀiµÕi˜VˆiÃʜvÊViÀÌ>ˆ˜ÊV>˜ViÀðÊ/ iÊÀi‡ Ãi>ÀV ÊÃÌÀœ˜}Þʈ“«ˆiÃÊÌ >ÌÊ>ÌÊÌ iÊÛiÀÞʏi>ÃÌÊÌ iÊ }i˜iÀ>Ê«ÕLˆVÊܜՏ`ÊLi˜iwÌÊÃÕLÃÌ>˜Ìˆ>ÞÊvÀœ“Ê }Ài>ÌiÀÊ>Ü>Ài˜iÃÃʜvÊÌ iÊLÀœ>`Ê« ÞȜœ}ˆV>Ê Li˜iwÌÃʜvÊۈÌ>“ˆ˜Ê ]Ê>ÊÜ՘`ʓi`ˆV>ÊVœ˜Ãi˜‡ ÃÕÃʜ˜ÊÃi˜ÃˆLiÊÃ՘ÊiÝ«œÃÕÀiÊ>˜`Ê>ÊVi>Àʈ˜`ˆV>‡ ̈œ˜Êœvʜ«Ìˆ“>ÊÀiVœ““i˜`i`Ê`>ˆÞʈ˜Ì>ŽiÃʜvÊ ÛˆÌ>“ˆ˜Ê ÊvÀœ“Ê`ˆiÌ>ÀÞÊÜÕÀViðÊÊ / Ê ,  ]Ê ° .OVEMBER   ,5#9 2%!$).' )++!.$!     
Purchase answer to see full attachment
User generated content is uploaded by users for the purposes of learning and should be used following Studypool's honor code & terms of service.

Explanation & Answer

Hello,I have submi...


Anonymous
I use Studypool every time I need help studying, and it never disappoints.

Studypool
4.7
Trustpilot
4.5
Sitejabber
4.4

Similar Content

Related Tags